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Abstract 
This qualitative design study collected Likert style survey data to describe 
feelings, perceptions, and attitudes of dental hygienists about their knowledge about oral 
HPV and its associated risks for OPC.  The research quantitatively analyzed the dental 
hygienists responses from the survey to determine if relationships exist based upon dental 
hygienists’ demographics and knowledge, comfort, and likelihood to discuss oral HPV 
and HPV vaccine options with patients.  The survey found that 81%of surveyed dental 
hygienists perform an intraoral exam on every patient they care for (n=341, 80.61%).  
The respondents also indicated that 49.88% (n=212) of dental hygiene patients complete 
a risk for oral cancer assessment.  As a whole, dental hygienists are aware the incidence 
of oral HPV in oropharyngeal cancers is rising (n=400, 96.15%).  They believe it is 
important for dental hygienists to provide oral HPV education to their patients and report 
feeling comfortable (n=257, 61.2%) and knowledgeable (n=296, 69.98%) to be doing so.  
However, the survey found 53.44% (n=225) of dental hygienists do not discuss the risk 
of oral cancers developing with HPV present and 61.81 (n=246) do not discuss the mode 
of transmission of oral HPV.  They feel they would be more comfortable and likely to 
discuss oral HPV education with patients if they had more knowledge on the subject.  
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Introduction 
 
Introduction to the Research Question   
Human papillomavirus (HPV) causes warts in the body and is the most common 
sexually transmitted infection in the United States of America (US) (Center for Disease 
Control and Prevention [CDC)] 2013b).  It is now known to be associated with 63% of 
oropharyngeal cancers (OPC) in the US and the annual incidence is rising (CDC, 2012a; 
CDC, 2012c; D’Souza et al., 2007; Gillison et al., 2012; Kreimer, Clifford, Boyle, & 
Franceschi, 2005; National Conference of State Legislatures (NCSL), 2011; Shiboski, 
Schmidt, & Jordan, 2005).  While head and neck cancers, including those of the oral 
cavity, have been declining over the last three decades, those OPC of the tonsils and base 
of the tongue have been increasing (Cleveland et al., 2011; Herrero et al., 2003; Shiboski 
et al., 2005).  Worldwide, research has shown 90% - 95% of tonsillar HPV-positive 
squamous cell carcinoma (SCC) is caused by a particular HPV type, HPV-16, presence in 
the lingual and palatine tonsillar regions (Cogliano et al., 2005; D’Souza et al., 2007; 
Dahlstrand & Dalianis, 2005; Gillison et al., 2000; Gillison et al., 2004; Herrero et al., 
2003; Kreimer, Clifford, Boyle & Franceschi, 2005; Kreimer, Clifford, Snijders, et al., 
2005; Licitra et al., 2009; Herrero et al., 2007).   
Although this information is available for dental hygienists, the questions arise: 
How many dental hygienists know this information and how many are discussing this 
with their patients?  This study aimed to determine whether dental hygienists are 
knowledgeable of oral HPV as well as if dental hygienists are addressing this topic with 
their patients.  If they are not, what are the barriers preventing them from doing so?  
 2 
DENTAL HYGIENISTS AND HUMAN PAPILLOMAVIRUSES     
 
Background of Study 
 
Based on estimates reported by the American Cancer Society (ACS), 36,000 new 
oral cavity cancers and OPC will be reported in 2013 resulting in predicted 6,850 deaths 
(ACS, 2013b).  Research now supports non-HPV (toxin/chemical induced) and HPV-
positive tumors as two distinct entities due to morphological characteristics and survival 
rates (D’Souza et al., 2007; Fakhry et al., 2008; Heck et al., 2010; Gillison et al., 2000; 
Klussman et al., 2009).  Previously, people at risk for oral cancer were those older than 
55 with reported histories of tobacco and alcohol use (ACS, 2013a; CDC, 2011; Oral 
Cancer Foundation (OCF), 2011; Shiboski et al., 2005).  The number of non-HPV OPC 
nationwide (n=28,144) declined significantly by annual percentage of change of negative 
185% (P<0.001) from 1982 to 2004 based from the Surveillance, Epidemiology and End 
Results (SEER) program (N=45,769) registry statistics (Chaturvedi et al., 2008).  HPV 
OSCC (n=17,625) incidences rose from 1973 to 2004 by an annual percentage of change 
of 80% (95% CI) (Chaturvedi et al., 2008).   
Dental professionals, both dentists and dental hygienists, are formally trained by 
nationally accredited educational institutes to perform intraoral and extraoral inspections 
to detect oral diseases for the patients in their care (CODA, 2013).  Dental hygienists are 
educated to provide screenings to detect suspicious areas or abnormal findings of the 
head and neck; while dentist perform the examination and diagnosis (Commission of 
Dental Accreditation [CODA], 2013).  The oropharynx is a difficult area to visually 
inspect as well as manually palpate.  Screening for HPV OPC and risk factors could be 
included in the current standard of dental hygiene care in preventing oral diseases 
(American Dental Hygienists’ Association [ADHA], 2008). 
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Statement of the Problem 
In the US, HPV OPC is projected to cause 2,370 new cases in women and 9,356 
new cases in men in 2013 (CDC, 2012c).  The cases of HPV OPC are 11,726 on average 
annually, second only to cervical cancer with 11,967 cases (CDC, 2012c).  This separates 
the two by 241 cases annually.  The number of HPV OSCC is expected to surpass the 
number of cervical cancers by 2020 (Chaturvedi et al., 2011).  In a recent small study 
(N=93) of people in the US, only 34% (n=32) of the respondents identified HPV as a risk 
for OPC (Dodd, Riley, & Logan, 2012).   
Dental care providers may be aware of the need to educate patients about the oral 
cancer risks associated with HPV; however, many may be withholding this patient 
education information due to feeling inadequately educated about emerging studies, 
discomfort discussing this topic with patients in the dental setting, and less 
knowledgeable about available vaccines (Daley et al., 2011).  Dental hygienists may not 
be aware of this new information, subsequently their patients may not be learning about 
the risk of oral cancer caused by HPV during their dental visits.  Dental hygienists may 
play a role in helping our communities understand this risk as well as help promote 
vaccination against HPV.   
Significance of the Study 
 
  The ACS reports that oral cancer claims one life every hour of every day in the 
US (ACS, 2012).  Two out of three OPC have HPV DNA present in the lesion (ACS, 
2013a).  According to the CDC, 20 million people are infected by HPV in the United 
States and there will be an estimated 6.2 million new cases each year (2011).  By the time 
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a woman reaches the age of 50, four out of five will have been infected with HPV at one 
point in their lives (CDC, 2013a).   
 Vaccines are currently available to protect against anogenital infection of HPV-16 
HPV-18, HPV-6, and HPV-11 (CDC, 2011; CDC, 2012c).  HPV-16 and HPV-18 cause 
70% of all cervical cancers (CDC, 2011; CDC, 2012c).  Thirty-five percent of oral 
cancers are HPV DNA positive with 90-95% of these cancers being specifically HPV-16 
positive (D’Souza et al., 2007; Kreimer, Clifford, Boyle & Franceschi, 2005).  There is 
currently no vaccination approved for oral HPV (CDC, 2011; CDC, 2012c).   
 The dental hygienist’s preventative role in oral health can be an integral part of 
improving an individual’s understanding about the risk of HPV in the mouth and may 
help young adults reconsider the behaviors they may consider as safe-sex such as oral sex 
and open-mouthed kissing.  Anhang, Goodman, and Goldie (2004) stated that due to the 
limited time for patient education during physician counseling sessions, clinical 
providers, such as nurse practitioners, should play an integral role in reviewing screening 
options and providing HPV information so women can be involved in their cancer 
screening choices.  Dental hygienists could possibly fulfill this role in the dental setting 
for oral HPV education.   
 The purpose of the study was to assess if dental hygienists are addressing the risk 
of HPV OPC and factors influencing the dental hygienists’ decisions to do so.  Currently, 
there has been no national assessment of dental hygienists’ perceptions and practice of 
oral HPV patient education and screenings.  This study attempted to answer the following 
questions: 
1. Are dental hygienists knowledgeable of the risks of oral HPV?   
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2. Are dental hygienists in the United States educating their patients about the 
risk of OPC caused by HPV? 
3. Are dental hygienists screening patients with intraoral screenings and risk 
assessment tools to determine their risk for oral HPV? 
4. Why are dental hygienists deciding to discuss or not discuss HPV OSSC? 
5.  Why are dental hygienists opting to discuss or not discuss HPV vaccination 
availability with their patients? 
Overview of the Methodology 
 
The purpose of the study was to investigate the perception and attitudes of dental 
hygienists regarding their role in educating patients of the risk of HPV OPC.  The data 
provided information about the frequency of oral cancer screenings (OCS), oral cancer 
risk assessments, knowledge of oral HPV, and perceptions and attitudes related to HPV 
OPC education with patients.  The study also investigated current feelings of dental 
hygienists about promoting HPV vaccination to their patients or parents of minor 
patients.  The research identified if and why dental hygienists may avoid discussing HPV 
with their patients as well as determined ways to best integrate oral HPV information into 
patient education sessions.  The goal of the study was to use the data to determine if 
deficiencies exist in dental hygienists’ OCS practice and oral HPV knowledge.     
Delimitations of the Study 
 
The delimitations of the study included the sample size, which also included 
population size variance between the selected states.  The sample from the states selected 
may not have provided generalization for all dental hygienists practicing within the US.  
The survey was self-reporting and states were conveniently selected so selection bias may 
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exist.  Dental hygienists who responded may be clinicians who feel strongly about the 
prevention of oral cancer and currently assume roles in educating patients about the risks 
of HPV; therefore, bias may have been present.  Clinicians who did not currently 
establish cancer risk assessment or practice oral cancer screenings may not respond to the 
questionnaire due to feelings of lack of relevance to practice or lack of knowledge.  
Therefore, results of the study may have underrepresented dental hygienists not including 
oral cancer awareness as part of their routine practice.    
Definition of Key Terms and Operational Definitions 
 
1. HPV, a type of DNA virus infecting the basal cells of stratified epithelium of 
skin or mucous membranes, is the most common sexually transmitted disease 
in the United States (CDC, 2013b; Cleveland et al., 2011).  The most common 
HPV-related cancer sites in the body are the mucous membranes of cervix, 
followed by those of the oropharynx (CDC, 2012c).   
2. Waldeyer’s tonsillar ring is formed by the both the palatal and lingual tonsils 
as well as the tonsillar tissue at the base of the tongue (CDC, 2012a; 
Cleveland et al., 2011; Heck et al., 2010; Herrero et al., 2003; Hoffman et al., 
2005; Shiboski et al., 2005).  The Waldeyer’s tonsillar ring forming the 
opening of the throat exhibits the highest prevalence of HPV (CDC, 2012a; 
Cleveland et al., 2011; Heck et al., 2010; Herrero et al., 2003; Hoffman et al., 
2005; Shiboski et al., 2005).  The American Joint Committee on Cancer 
defines the oropharyngeal tumor sites as those occurring on the base of the 
tongue, soft palate, uvula, palatine tonsil fossa, tonsillar pillars, and 
oropharynx (CDC, 2012c; Cleveland et al., 2011).   
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3. Oral cavity tumors include those located on the vermillion border of the lips, 
labial mucosa, tongue, gingiva, floor of the mouth, hard palate, parotid and 
submandibular glands, and other oral mucosa (CDC, 2012a; Cleveland et al., 
2011).  These tumors are commonly associated with a history of tobacco and 
or alcohol use (CDC, 2012a; Cleveland et al., 2011). 
4. According to Standard 2-17 of the Commission on Dental Accreditation of the 
American Dental Association (CODA) in January 2013, dental hygiene 
graduates must have competence in providing the dental hygiene process of 
care; specifically in the collection of patient findings related to physical and 
oral health status of the patient (CODA, 2013).  The dental hygienist is 
significant in the delivery of comprehensive patient health care as a member 
of the dental team (CODA, 2013).  The process of dental hygiene of care is a 
vital component of preventive approaches and total patient care (CODA, 
2013).  
5. Dental hygienists, as stated by the American Dental Hygienists’ Associations’ 
(ADHA) Standards for Clinical Dental Hygiene Practice (2008), practice the 
recognition, treatment, and prevention of oral diseases.   
Summary 
 
The number of oropharyngeal squamous cell carcinomas (OSCC) caused by HPV 
is expected to surpass the number of cervical cancers by 2020 in the US (Chaturvedi et al, 
2011).  As these numbers increase, the role of the dental hygienist as the preventative 
specialist will be critical in educating patients about the risks associated with HPV 
exposure through sexual contact including oral sex and open-mouthed kissing (D'Souza, 
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Agrawai, Halpern, Bodison, & Gillison, 2009).  It is the responsibility of the dental 
hygienist to screen all patients for signs of head and neck cancers including those caused 
by HPV.  The dental community may find guidance from the medical community 
regarding proactive practice to promote the detection of HPV orally, which could lead to 
an annual decline in the number of HPV OSCC cases.  It is predicted that the majority of 
head and neck cancers in 2030 will be those caused by HPV (Chaturvedi et al., 2011). 
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Review of the Literature 
 
Overview of Research 
This review of the literature looks at the HPV virus, it’s incidence in men and 
women, and associated risk factors.  Screenings and vaccination for cervical HPV are 
also discussed.  A brief review of oral cancer discusses risk factors for non-HPV oral 
cancer.  Incidence, evidence, risk factors, and survival rates for HPV OPC are 
investigated.  Studies conducted to determine the frequency of OCS and oral cancer 
patient education completed by dental hygienists, nurses, dentist, and physicians are 
researched.  The review also includes studies that analyzed dental professionals’ 
perceptions about oral HPV.  There is limited research related to the dental hygienists’ 
perception in their role in educating patients about HPV.  Therefore, sources from 
nursing and their methods in educating communities and patients about HPV are also 
examined.  
Related or Theoretical Frameworks and Supporting Research 
Overview of HPV.  HPV is a DNA virus that causes wart, papillomas, in various 
locations of the body through skin-to-skin contact from infected individuals through cuts, 
abrasion, or small tears in the outer skin layer of uninfected individuals (Mayo Clinic, 
2013).  The virus then infects the basal cells of stratified epithelium of skin or mucous 
membranes, like those of the cervix and oropharynx (Cleveland et al., 2011).  There are 
more than 100 varieties of HPV (Lehne, 2010; Mayo Clinic, 2013).  HPV causes 
common warts (hands, fingers and fingernails), plantar warts (feet and heels), flat warts 
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(face, neck, hands, wrists, elbows, and knees), and genital warts (vulva, anus, cervix, 
penis, and scrotum) (Mayo Clinic, 2013).  HPV DNA does not enter the blood stream of 
the body, so it is not believed that HPV in one location of the body will not cause new 
infection in another area of the body systemically (National Cancer Institute, 2012).   
Genital HPV can be acquired through vaginal or anal sexual intercourse with an 
infected partner and is the most common sexually transmitted infection in the US (CDC, 
2013b; Lehne, 2010; Muñoz et al., 2003; Watson et al., 2008).  There are typically no 
signs or symptoms in most infected individuals (CDC, 2013b).  Fifty percent of sexually 
active people will contact genital HPV once during their lifetime (CDC, 2011; Lehne, 
2010).  Women and men with only one sex partner in their lifetime can still get HPV 
(CDC, 2013b).  At any one time, one person of 100 sexually active adults will have 
genital warts caused by HPV (CDC, 2011).  By the time women are 50 years old, 4 of 5 
will have been infected by HPV at some point in their lives (CDC, 2013a).   
HPV can also cause cellular changes in infected mucosal tissue that can lead to 
cancer (Mayo Clinic, 2013).  Thirty of the more than 100 HPV strains are known to be 
carcinogenic to human beings (CDC, 2013b; Cogliano et al., 2005; International Agency 
for Research against Cancer (IARC), 2007; Lehne, 2010).  Particularly, these oncogenic 
or high-risk HPV (HR-HPV) types are HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, 
-58, -59, and -66 (Cogliano et al., 2005).  The most common HPV-related cancer site in 
the body is the cervix, followed by the oropharynx (CDC, 2012c).  HPV is known to be 
involved in the development of subset anogenital cancers of the vagina, vulva, urethra, 
penis, and anus (ACS, 2012; CDC, 2011; CDC, 2013a; Cogliano et al., 2005; Lehne, 
2010; NCSL, 2011).  There is at least some association with HPV and cancers of the 
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larynx and periungual, around the fingernail, skin (ACS, 2012; CDC, 2013a; Cogliano et 
al., 2005; NCSL, 2011).  
HPV-16, HPV-18, HPV-31, and HPV-33 have been identified as the oncogenic, 
HR-HPV types present in cervical, anal, and head and neck cancers (CDC, 2013a; 
Gillison et al., 2000; Schwartz et al., 1998).  HPV-16 and HPV-18 are present in more 
than 90% of non-cervical HPV cancers, with HPV-16 association in the majority of these 
(Clifford, Smith, Plummer, Muñoz, & Franceschi, 2004).  HPV-18 is rarely detected in 
the oropharynx (Kriemer et al., 2004).  Low-risk types, HPV-6 and HPV-11, cause 95% 
anogenital warts in men and women (Lehne, 2010).  HPV-6 and HPV-11 are also 
associated with laryngeal carcinoma, and uncommon Buschke-Löwenstein cancers of the 
vulva, penis, and anus (Cogliano et al., 2005).  In 90% of HPV infections, the disease will 
be eliminated from the body without the individual ever knowing they were infected 
(CDC, 2013c).  
 Non-oropharyngeal HPV in men.  In 2011, Anne Schuchat, M.D., director of 
the National Center for Immunization and Respiratory Diseases at the United States 
CDC, reported approximately 7,000 HPV associated cancers each year affect men in the 
US (CDC, 2011; CDC, 2013b; OCF, 2011).  It is estimated that 60% of men in the US 
are infected genitally by HPV (Chung and Gillison, 2009; Nielson et al., 2007; Partridge, 
et al., 2007).  Penile cancers are rare, occurring approximately in 600 cases each year, 
while 1,500 anal cancers occur each year (CDC, 2013b).  Immune system deficiency in 
men increased the risk of developing anal cancer from HPV as well as more severe cases 
of genital warts (CDC, 2013b).  HPV has a median duration of 7-52 months in men, 
while HPV-16, particularly, has a mean duration of 12-19 months in men (Giuliano, Lee, 
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et al., 2011).  Clearing the HR-HPV infection decreases in those men having at least 50 
female partners (Giuliano, Lee, et al., 2011).  It is worth noting that men with only one 
sex partner in their lifetime can still develop a HPV infection (CDC, 2013b).   
 The natural history of HPV in men is relatively unknown (CDC, 2013b; Giuliano 
et al., 2008).  Flores and colleagues’ (2008) findings predict that the cervical epithelium 
is a more favorable environment for viral replication compared to the skin epithelium 
environment, but factors for this have not been identified.  The penile shaft appears to 
play a role in transmission of HPV in men, because HPV-16 viral replication and 
autoinoculation were found to occur in this area (Flores et al., 2008).  Flores and 
colleagues (2008) found HPV genital infection sites with close proximity in males’ 
resting anatomy might possibly inoculate uninfected areas. These sites include perianal 
and anal canal, perianal and scrotum, scrotum and glans/corona, or scrotum and penile 
shaft (Flores et al., 2008).  Humidity, temperature, and possibly poor hygiene could 
possibly also contribute to viral replication in these areas (Flores et al., 2008).  Further 
studies are recommended to confirm this theory (Flores et al., 2008).   
 Clearance of HPV increases in men as they age (Giuliano, Lee, et al., 2011).  The 
incidence of new HPV genital infection was 38.4 in 1000 people per month in Giuliano 
and colleagues’ 2008 study of men (N=1159) ages 18-70 in Brazil, Mexico, and the US 
from general populations, universities, and organized health-care systems.  These men 
were considered healthy after testing HIV-negative and having no history of penile or 
anal cancer; no penile discharge; no burning with urination; no current sexually 
transmitted diseases; no drug treatment in the last 6 months; and not being homeless or 
imprisoned within the last 6 months (Giuliano, Lee, et al., 2011).  Having a high number 
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of lifetime female sexual partners (50 female partners vs. 1 female partner) and number 
of anal-sexual male partners (3 male partners vs. no male partners) increased the risk for 
men to develop HR-HPV infection (Giuliano, Lee, et al., 2011).  The development of 
anal cancer is approximately 17 times more likely for gay and bisexual men than 
heterosexual men (CDC, 2013b).     
 Cervical HPV in Women.  Cervical cancer is the second most common cancer in 
women in the world (Cogliano et al., 2005).  The cervix is the passageway from the 
vagina to the uterus (Mayo Clinic, 2013).  Cervical cancers primarily occur in the 
cervical transformation zone, which is a ring of tissue located at the meeting of the 
squamous epithelium of the vagina and the glandular epithelium of the endocervical canal 
(Schiffman et al., 2011).  Researchers believe cervical cancer is caused solely by HR-
HPV chronic infection (Cogliano et al., 2005; CDC, 2012c) and is responsible for 
275,000 deaths per year in the world with 240,000 of those deaths per year in the 
developing countries due to lack of available screening programs (CDC, 2012c; Cogliano 
et al., 2005).  
 Half of new HPV infections are undetectable in the first 6-12 months (Schiffman 
et al., 2011).  In 90% of exposed and infected individuals (men and women), HPV 
infections typically clear within 2 years and these patients are be presumed uninfected 
after clearance of the HPV infection (Cogliano et al., 2005; Lehne, 2010; Muñoz et al., 
2003; Schiffman et al., 2011).  There are typically no signs or symptoms in most HPV 
infected individuals (CDC, 2013b).  Therefore, most HPV infections do not progress to 
invasive genital cancer and most HPV clears from the patient without requiring 
treatment; thus, HPV infected individuals may not be aware they have or have had the 
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virus (Watson et al., 2008; Dunne et al., 2007; Schiffman, Castle, Jeronimo, Rodriguez, 
& Eacholder, 2007).  Evidence has shown that the HR-HPV cervical infections tend to 
last longer than the low-risk HPV infections types (Muñoz, Bosch, et al., 2004).  True 
cervical cancer lesions are those that persist and have progressed over a period of several 
years if left untreated (McCredie et al., 2008).  There is no association with infection of 
one HPV type and the likelihood of or duration of persistence of another HPV type 
(Schiffman et al., 2011).   
 Risk factors for HPV cervical infection.  Some studies have identified cigarette 
smoking, long-duration usage of oral contraceptives, and multiple live births (>3 
children) to increase the risks for progression of cervical HPV infection (Appleby et al., 
2007; Cogliano et al., 2005; Collins, Rollason, Young, & Woodman, 2010; Gravitt, 2011; 
Muñoz, Méndez, et al., 2004; Plummer et al., 2003).  However, according to the Working 
Group for the World Health Organization of IARC in 2005, the role of hormonal 
contraceptives and nutrients in HPV association with cervical cancer is unclear (Cogliano 
et al., 2005).  Muñoz, Méndez, and colleagues (2004) did not find a relation between 
smoking and cervical HPV infection.  Schiffman et al. (2011) explains that the 
mechanism for the exposures to these risk factors remains unclear. 
 Certain HR-HPV strains (HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -
59, -66) have been proven to cause nearly 100% of invasive cervical cancers in the world 
(Cogliano et al., 2005; IARC, 2007; Watson et al., 2008).  An estimated 70% of cervical 
cancers worldwide are caused by chronic infection of HPV-16 and HPV-18 with the 
remaining 30% caused by these other oncogenic HPV types (Clifford et al., 2004; 
Muñoz, Méndez, et al., 2004; Muñoz et al., 2006; Watson et al., 2008). 
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 Incidence of HR-HPV types in women younger than 40 years of age is associated 
with age, new sex partners, increased parity, and recent pregnancy (Muñoz, Bosch, et al., 
2004).  Low-risk cervical HPV for young women (<40 years) occur more frequently in 
relation to number of sex partners and recent pregnancy (Muñoz, Bosch, et al., 2004).  
Women older than 40 years of age appear to have an increased incidence of developing 
cervical HR-HPV by having new sex partners (Muñoz, Bosch, et al., 2004).  
Epidemiologic studies offer strong associations between HPV incidence and a new sexual 
partner, concluding that even in women older than 40 years of age, risky sexual behavior 
drives most HPV infection (Muñoz, Bosch, et al., 2004; Trottier et al., 2010).  
  Cervical HPV is highest in adolescence and early adulthood; drops in mid-life; 
and rises again in older adulthood in many countries (Franceschi et al., 2006; Heck et al., 
2010).  Exposure to HPV is high around the time of first sexual intercourse, sexual debut, 
regardless of age because women have not had previous HPV exposure and therefore, 
have not acquired immunity (Muñoz et al., 2003).  Generational behavioral changes, 
which may be spurring earlier HPV incidence, include younger age of sexual debut, 
greater numbers of sexual partners, and higher likelihood of engaging in oral sex (Caron 
& Moskey, 2002; Haddow et al., 2006; Heck et al., 2010).  The US, Australia, Russia and 
Brazil have found similar evidence of these generational differences in HPV prevalence 
and sexual behavior while India and Italy have not (Heck et al., 2010).   
 Differences of ethnicity/race and cofactors of tobacco use full term pregnancy or 
parity, socio-economic status, and reduced access to healthcare may contribute to 
incidence rate variations of progression from HPV infection to cervical cancer (Benard et 
al., 2008; Castellsagué & Muñoz, 2003; Farley, Risinger, Rose, & Maxwell, 2007; 
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Parikh, Brennan, & Boffetta, 2003; Watson et al., 2008; Schiffman et al., 2011).  In the 
US, cervical cancer incidence is higher in African American and Hispanic women and 
women living in the South (Watson et al., 2008).  In comparison to Caucasian women in 
the US, African American women are 50% more likely to be diagnosed with cervical 
cancer and twice as likely to die from this cancer each year (Crates, Brewer, Fazeka, 
Mitchell, & Smith, 2009).        
 HPV screening and testing.  Currently, there are two methods to detect HPV 
presence to protect against cervical cancer (CDC, 2013c; Schiffman et al., 2011; Watson 
et al., 2008).  The Papanicolaou (Pap) test uses cervical cytology screening for abnormal 
cell changes in an exfoliated cervical cell sample collected from the cervix (CDC, 2013c; 
Schiffman et al., 2011; Watson et al., 2008).  The Pap test more readily identifies SCC 
versus adenocarcinomas (CDC, 2013c; Smith et al., 2000; Schiffman et al., 2011; Watson 
et al., 2008). Currently, there is no FDA approved HPV screening method for men nor for 
anal, vulvar, vaginal, penile, or oropharyngeal HPV (CDC, 2013b).   
 HR-HPV DNA screening tests for the presence of the HR-HPV virus types in the 
sample (CDC, 2013c; Watson et al., 2008).  The U.S. Food and Drug Administration 
(FDA) recommends restricting HPV DNA screening to women over 30 years of age 
because they are past the peak of acute HPV infection which results in more positive 
predictive value of HPV testing due to higher proportions of these women having 
persistent HPV infections (Schiffman et al., 2011).  Women younger than 30 have a 
higher frequency of false-positive occurrence due to their higher rates of acute HPV 
transient infections caused by increased number of sexual partners and lack of HPV 
immunity (Anhang et al., 2004; Schiffman et al., 2011).  DNA testing for HR-HPV in 
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conjunction with Pap test screening is recommended for management of previous Pap 
abnormal results in women over the age of 30 years (Smith, Cokkinides & Eyre, 2006; 
Watson et al., 2008; Wright et al., 2007).   
 HPV vaccination availability and acceptance.  Two prophylactic vaccines, 
Gardasil® [Merck] and Cervarix® [GlaxoSmithKline], have been evaluated by 
randomized controlled trials and shown to demonstrate nearly complete cervical disease 
protection from their target HPV stains in previously uninfected women for 8 years  
(CDC, 2011; CDC, 2012c; NCSL, 2011).  Gardasil®, the quadrivalent vaccine (HPV4), 
targets HPV-16, HPV-18, as well as HPV-6 and HPV-11 thus protecting against 
anogenital warts in men and women (CDC, 2011; CDC, 2012c; NCSL, 2011).  Gardasil® 
has been shown to protect men age 16-26 in the development of external genital lesions 
(N=4065) (Giuliano, Palefsky, et al., 2011).  Cervarix®, the bivalent vaccine (HPV2), 
targets HPV-16 and HPV-18 (CDC, 2012c; NCSL, 2011).  These vaccines both protect 
against HPV in the vulva, vagina, anus, and cervix (CDC, 2012c).  Both vaccines require 
a 3-dose schedule over a 6-month period (CDC, 2012c). 
 In 2006, the National Advisory Committee on Immunization Practices 
recommended a HPV vaccine for all females age 11 to 12 to protect against HPV-16 and 
HPV-18 (NCSL, 2011).  They also recommended vaccination for unvaccinated teen girls 
and women younger than 26 years of age (NCSL, 2011).  In 2011, this same committee 
announced the recommendation to the CDC for vaccination with Gardasil® for boys age 
11 to 12.  The committee also recommended for non-vaccinated men ages 13- 21 years to 
be vaccinated (CDC, 2011).  Both vaccines do not eliminate pre-existing HPV infections 
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in men or women, so vaccination is recommended before individuals become sexually 
active (Lehne, 2010).  
 Kreimer et al. note (2004) HPV-16 and HPV-18 have been detected in almost all 
head and neck SCC biopsies, suggesting the vaccine for cervical cancer caused by these 
HPV types should be relevant (Kreimer et al., 2004).  HPV oral prevalence is less than 
2% in 12-17-year-olds (Schlecht, 2012).  At this time, neither Gardasil nor Cervarix has 
been approved for the prevention of oral and OPC (CDC, 2011).  In a beagle model, 
however, the vaccine completely prevented oral infection of canine oral papillomavirus 
(Schlecht, 2012).  However, it will be decades before the prevention possibility of these 
vaccines in HPV OPC is known (Cleveland et al., 2011; Schlecht, 2012).   
 The required three parenteral doses, lack of overall HR-HPV protection, and the 
relatively high cost of administration are the limitations of the current vaccines in all 
countries (Kane, 2012).  The burden of cervical cancer is the highest in the poorest 
countries of the world (Kane, 2012).  School-based vaccination programs in these 
countries create the highest potential for complete coverage (Kane, 2012).  Reaching 
preadolescents in developing countries serves the highest challenge because; although 
these countries effectively deliver the first dose of HPV-vaccines at a relatively high 
coverage rate to children up to 2 years of age, vaccinating the preadolescents is less-
routine (Kane, 2012).    
 Fang, Coups, and Heckman (2010), surveyed 1,383 respondents selected from the 
2007 Health Information National Trends Survey (N=7,674).  Fang, Coups, and 
Heckman (2010) aimed to determine HPV acceptability in this sample of the national 
population who had a daughter under the age of 18 living in their household.  Fang et al. 
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(2010) was limited by analyzing willingness versus vaccine uptake rates; respondents 
may not have been parents or legal guardians; and sample selection may have led to 
hypothetical answers if not applicable (Fang et al., 2010).  However, parents who believe 
cancer can be cured if detected early report being supportive of HPV vaccination for their 
children (Fang, Coups, & Heckman, 2010).  The most common reason for individuals’ 
reluctance to vaccinate their children with an HPV vaccine is lack of information and 
knowledge about the vaccines (Fang et al., 2010).  One in five people who are opposed or 
undecided about HPV vaccination are concerned with safety (Fang et al., 2010).  Fang 
and colleagues (2010) suggest if the perception of insufficient vaccine information exists, 
personal behaviors and personal health belief about cancer have more impact on 
individuals’ decision to vaccinate versus background or prior experiences.   
 History of oral cancer.  Chemical/toxin induced oral cancers, or non-HPV oral 
cancers, have been predominantly detected in men over the age of 55 (ACS, 2013a; CDC, 
2011; OCF, 2011).  They most commonly located in the oral cavity, particularly on the 
lateral border of the tongue and the floor of the mouth (Cleveland et al., 2011; Gillison et 
al., 2008).  These oral cancers have been shown to be associated by certain risk factors 
including  
 tobacco smoking (D’Souza et al., 2007; Negri, La Vecchia, Franceschi, & Tavini, 
1993; Franceschi et al., 1999; Gillison et al., 2000; Gillison et al., 2008; Smith et 
al., 2004; Talamini, 2000);  
 alcohol consumption (D’Souza et al., 2007; Negri, La Vecchia, Franceschi, & 
Tavini, 1993; Franceschi et al., 1999; Gillison et al., 2000; Gillison et al., 2008; 
Smith et al., 2004; Talamini, 2000); 
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 poor oral hygiene (D’Souza et al., 2007; Gillison et al., 2008);  
 sun (de Visscher, Grod, Otter, can der Waal, 2002 cited by Bigelow, Patton, 
Strauss, & Wilder, 2007); and  
 low fruit and vegetable diet (Negri, La Vecchia, Franceschi, & Tavini, 1993; 
Talamini, 2000; Franceschi et al., 1999).   
Talamini and colleagues found no association with mouthwash with low alcohol content 
in 2000.  Since 1993, 80% of oral cancers have been associated with tobacco and heavy 
alcohol consumption as well as a smaller risk from eating little fresh fruit and vegetables 
(Negri, La Vecchia, Franceschi, & Tavini, 1993; Talamini, 2000; Franceschi et al., 1999).  
No evidence exists for an association of oral cavity and sexual behaviors (Heck et al., 
2010; Herrero et al., 2003).  Tobacco use and alcohol consumption are the primary risk 
factors for chemical/toxin induced, or non-HPV, related oral cancers around the world 
(Gillison et al., 2000; Applebaum et al., 2007; Herrero et al., 2003; Smith et al., 2004; 
Schwartz et al., 1998; Gillison et al., 2008; Kreimer et al., 2004).   
 In 2004, Castellsague et al. (as cited by Ragin, Modugno, & Gollin, 2007) found 
alcohol and tobacco use have a synergistic effect of increased risk of head and neck SCC 
in a dose-response fashion.  Herrero and colleagues’ study (2003) identified smoking as a 
strong risk factor for oral cancer, including the oropharynx.  They also found a dose-
response relationship to exist between increasing numbers of smoked cigarettes per day 
and cancer risk (Herrero et al., 2003).  This same relationship exists for years of smoking 
as well as alcohol drinks and years of drinking (Herrero et al., 2003).  In India, a strong 
association is clear for oral cancer risk and chewing native gutka (with tobacco) or betel 
quid (Herrero et al., 2003; Sankaranarayanan et al., 2006).   
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 Incidence of oral HPV and OPC.  The annual incidence of OPC is increasing 
(CDC, 2012a; Chaturvedi et al., 2008; Chaturvedi et al., 2011; Gillison et al., 2000; 
Gillison et al., 2008; Gillison et al., 2012; Shiboski et al., 2005;).  There has been an 
increase of 6.2% in men and 1.4% in women per year with HPV OSCC (CDC, 2012b; 
CDC, 2012c).  In the US, 11,726 HPV OPC cases are diagnosed each year with projected 
2,370 new cases in women and 9,356 new cases in men in 2013 (CDC, 2012c).  HPV is 
known to be associated with 63% of oropharyngeal cancers (OPC) in the US (CDC, 
2012a; CDC, 2012c; D’Souza et al., 2007; Gillison et al., 2012; Kreimer, Clifford, Boyle, 
& Franceschi, 2005; National Conference of State Legislatures (NCSL), 2011; Shiboski, 
Schmidt, & Jordan, 2005).  Worldwide, oncogenic HPV DNA is detected in 26% of all 
squamous cell carcinomas (SCC) in the head and neck (D’Souza et al., 2007; Kreimer, 
Clifford, Snijders, et al., 2005).   
 Gillison and colleagues’ 2012 national study found a 6.9% prevalence of HPV in 
the oral cavity of men and women ages 14-69 in the US; thus confirming the increasing 
risk of oral cancer caused by HPV. Gillison et al. (2012) found 10.1% HPV prevalence in 
men compared to 3.6% in women (p<0.001, unadjusted PR, 2.80, 95%CL, 2.02-3.88) in 
the US, creating a 3-fold increase in men.  Oral HPV-16 presence was detected in 1.6% 
in men and 0.03% in women (p=0.001; PR, 5.41; 95% CI; 2.12-13.83; Gillison et al., 
2012).  Overall, HPV-16 was detected in 1% of American men and women, analogous to 
an approximate 2.13 million individuals in the US (Gillison et al., 2012).  Race was not 
significant (p=0.06; Gillison et al., 2012).  As in worldwide incidence, men in the US 
also show higher incidence than women with OPC (CDC, 2012b; Chaturvedi et al., 2008; 
Chaturvedi et al., 2011; Gillison et al., 2008; Gillison et al., 2012).   
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 Gillison and colleagues’ 2012 study did not show a significant difference of 
incidence in either race.  In recent years, younger age groups (<55 years) have had an 
increased incidence of HPV-16 OPC (Chaturvedi et al., 2008; Chaturvedi et al., 2011; 
Gillison et al., 2012; Hammarstedt et al., 2006; Shiboski et al., 2005).  Chaturvedi et al. 
(2011) predict the incidence of OSCC positive for HPV will surpass cervical cancers by 
2020 and by 2030 will account for the majority of all head and neck cancers. 
 Evidence of HPV OPC.  HPV DNA, specifically HPV-16, was detected in head 
and neck cancers of the tongue, tonsils, and pharynx as early as 1989 (Schwartz et al., 
1998).  It was the similar morphologic features of HPV lesions found genitally and orally 
that raised the possibility of SCC caused by HPV in the oral, oropharyngeal, and 
laryngeal cavities (Syrjänen, 2007).  Basaloid SCC is found to be poorly differentiated 
and non-keratinizing in the head and neck (Dai et al., 2004; Gillison et al., 2000; Fakhry 
et al., 2008; Heck et al., 2010).  The tonsils’ squamous cell epithelium and lymphatic 
tissue’s juxtaposition may have similar complicated properties as that of the cervix uteri’s 
squamous-columnar junction (Kreimer et al., 2004; Winer et al., 2003).  The invaginating 
crypts of the oropharynx create extensive epithelial surface areas, which expose layers of 
these basal epithelial cells (Kreimer et al., 2004).  Molecular, epidemiological, and 
clinical data indicate the strong and consistent relationship between OPC and HPV 
(Applebaum et al., 2007; Chaturvedi et al., 2011; D’Souza et al., 2007; Gillison et al., 
2000; Gillison et al., 2008; Hansson et al., 2005; Herrero et al., 2003; Schwartz et al., 
1998; Smith et al., 2004).   
 “HPV associated” oral tissues are those of the oropharynx most commonly found 
in literature to be strongly associated with HPV infection, specifically of the lingual and 
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palatine tonsils and the base of the tongue, collectively known as Waldeyer’s ring (CDC, 
2012a; Cleveland et al., 2011; Heck et al., 2010; Herrero et al., 2003; Hoffman et al., 
2005; Shiboski et al., 2005).  HPV-positive tumors have also been less commonly 
detected throughout the oral cavity, head, and neck (CDC, 2012a; Cleveland et al., 2011; 
Heck et al., 2010; Herrero et al., 2003; Hoffman et al., 2005; Shiboski et al., 2005).  The 
anterior two-thirds of the tongue, gingiva, floor of the mouth, palate, and unspecified 
parts of the mouth and larynx are generally considered non-HPV cancer sites (CDC, 
2012a; Cleveland et al., 2011).  It is unclear why HPV tumors occur more frequently in 
the oropharynx rather than the oral cavity (Kreimer et al., 2004; Herrerro et al., 2003).   
 Evidence of HR-HPV OPC.  Many studies detected several HR-HPV types, 
predominantly HPV-16, present in these tumors of the oropharyngeal and tonsillar 
regions (Broutian, He, & Gillison, 2011; CDC, 2013a; D’Souza et al., 2007; Gillison et 
al., 2000; Heck et al., 2010; Herrero et al., 2003; IARC, 2007; Kreimer et al., 2010; 
Kreimer, Clifford, Boyle, et al., 2005; Kreimer, Clifford, Snijders, et al., 2005; Muñoz et 
al., 2003; Ramqvist & Dalianis, 2010; Schwartz et al., 1998).  Schwartz et al. (1998) 
found HPV-16 in 16.5% (41 of 248) of OSCC.  Smith et al. (2004) detected 15% HPV 
DNA in oral cavity cancers and 28% HPV DNA of OPC from exfoliated oral cell 
samples.  However, later studies found HPV-16 present as high as 80% - 95% in all OPC 
(Cogliano et al., 2005; Gillison et al., 2000; Gillison et al., 2004; Kreimer, Clifford, 
Boyle et al., 2005; Muñoz et al., 2003).  Most recently, D’Souza et al. (2007) and 
Kreimer et al. (2010) found HPV-16 to cause approximately 40% to 60% of OPC.  
 Shiboski et al. (2005) evaluated incidence data from 1973-2001 from the SEER 
program related to oral and pharyngeal cancer.  Patients (N=2,262) ages 20-44 years with 
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oral SCC and patients (N=1,251) with pharyngeal SCC (not including the nasopharynx) 
were evaluated (Shiboski et al., 2005).  In that time range, oral SCC incidence decreased 
by 52% in adult men, and only slightly decreased in women (Shiboski et al., 2005).  Oral 
tongue SCC annual incidence rates were twice as high as pharyngeal tongue SCC 
(Shiboski et al., 2005).  In Caucasian men ages 20-44, a statistically significant increase 
in oral tongue, base of tongue, and tonsillar SCC incidence was noted while all other oral 
cavity SCC incidence sites decreased (Shiboski et al., 2005).  Tonsillar and base of 
tongue SCC also increased while all other pharyngeal sites remained constant (Shiboski 
et al., 2005).   
 Chaturvedi et al. (2011) found 70% of OPC to be caused by HPV infection.  This 
study suggests OSCC population-level incidence changes in the US are caused by HPV 
infection (Chaturvedi et al., 2011).  This study also showed a 225% increase in of HPV 
OSCC in the US from 1988 to 2004 (Chaturvedi et al., 2011).  However, almost half of 
the specimens came from Hawaii and from west of the Mississippi River, leaving the 
eastern states unaccounted for (Mroz, Forastiere, & Rocco, 2011).   
 Evidence of HPV-16 in tonsillar tissue.  Worldwide, research has shown 90% - 
95% of tonsillar HPV-related SCC is caused by HPV-16 presence in the lingual and 
palatine tonsillar regions (Cogliano et al., 2005; D’Souza et al., 2007; Dahlstrand & 
Dalianis, 2005; Gillison et al., 2000; Gillison et al., 2004; Herrero et al., 2003; Kreimer, 
Clifford, Boyle, et al., 2005; Kreimer, Clifford, Snijders, et al., 2005; Licitra et al., 2006; 
Herrero et al., 2007; Ramqvist & Dalianis, 2010).  The Shiboski et al. (2005) research 
was the first to show the increase in cancers in the tonsils of younger adults.  The 
research authors discredit changes caused by increase in diagnosing over this period 
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because these incidence changes were not apparent in other age groups and (Shiboski et 
al., 2005). 
 Base of tongue tumors also increased in Stockholm from 1998-1999 to 2006-2007 
by 54% to 84% respectfully (Ramqvist & Dalianis, 2010).  In Sweden, there is a 2.8-fold 
increase in tonsillar cancer in the Stockholm area (Ramqvist & Dalianis, 2010).  The 
opposing rate changes in HNSCC and OSCC suggest that in 10 years half of all Sweden's 
HNSCC will be OSCC (Ramqvist & Dalianis, 2010).  OSCC currently account for one-
third of all HNSCC yearly in Sweden (Ramqvist & Dalianis, 2010).  Ramqvist and 
Dalianis (2010) found HPV positivity in 93% of all tonsillar cancers in 2006-2007.  From 
1970-2007, there was a 7-fold increase in HPV-positive tumors and a pattern of doubling 
incidence with each decade (Ramqvist & Dalianis, 2010).  
 Risk Factors for HPV Oropharyngeal Presence.  In 2007, the IARC 
acknowledged HPV infection, particularly HPV-16, as an independent risk factor for 
OSCC.  Many studies have shown HPV cancers of the head and neck, including those of 
the oral cavity and oropharynx, to be caused by HPV-16 infection (Applebaum et al., 
2007; D’Souza et al., 2007; Gillison et al., 2000; Hansson et al., 2005; Heck et al., 2010; 
Herrero et al., 2003; IARC, 2007; Muñoz et al., 2003; Ramqvist & Dalianis, 2010; 
Schwartz et al., 1998).  Several measures of sexual behavior have also been identified as 
risk factors for HPV head and neck cancers of the oral cavity and oropharynx 
(Applebaum et al., 2007; D'Souza et al., 2009; Gillison et al., 2004; Gillison et al., 2008; 
Herrero et al., 2003; Schwartz et al., 1998; Smith et al., 1998; Smith et al., 2004).  
Tobacco, alcohol and marijuana risk associations are also considered. 
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 Sexual behavioral risk for HPV oropharyngeal presence.  In 1998, Schwartz and 
colleagues studied 18-65-year-old males and females (N=284) from Washington.  These 
individuals had no history of oral cancer but had been recently diagnosed with oral SCC 
between 1990 and 1995 (Schwartz et al., 1998).  In-person interviews were completed 
determining the person’s demographic characteristics and asking questions of the 
person’s lifetime history of sexually transmitted diseases (including history of genital and 
oral warts); sexual practices history (3 or more sexual activities per month); and age of 
sexual debut (Schwartz et al., 1998).  Subjects were also asked about sexual activities 
including the lifetime number of opposite sexual partners; ever having oral sex with the 
opposite sex; number of oral sexual partners with the opposite sex; and sexual orientation 
since puberty (males) (Schwartz et al., 1998).  Schwartz et al. (1998) found young age at 
first sexual intercourse to be a risk factor for men with HPV and oral SCC.  They also 
found an association of increased risk for oral HPV and a history of genital warts. 
 Herrero and colleagues (2003) analyzed 1,415 tumors of the oral cavity patients 
and 225 patients with tumors in the oropharynx from Italy, Spain, Northern Ireland, 
Poland, India, Cuba, Canada, Australia, and Sudan (N=1670 case patients; N=1732 
control subjects) from 1996 to 1999 for IARC.  They compared oral exfoliated cells and 
blood samples to tumor tissue samples (Herrero et al., 2003).  HPV was detected more 
frequently overall in oral cancer (oral cavity and oropharynx) patients with more than one 
sexual partners and who practiced oral sex, thus suggesting a sexual transmission 
possibility (Herrero et al., 2003).  D’Souza and colleagues’ (2007) case-control study of 
newly confirmed patients with OSCC (N=100) in 2000-2005 suggests when HPV-16 
prevalence is detected in exfoliated oral cells, the chance of OPC development increases 
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by greater that 13-fold.  D’Souza and colleagues found increased significant association 
with OPC and number of vaginal-sex partners (p=0.002), oral-sex partners (p=0.009), 
and high lifetime number of these partners (D’Souza et al., 2007).  Comparatively, 
Gillison, D’Souza, Westra, and other colleagues (2008) reported HPV-16 positive tumors 
are related to several measures of sexual behavior, HPV-16 exposure, oral HPV-16 
infection, and seropositivity for any of four HR-HPV types (16, 18, 31, 35) (Gillison et 
al., 2008).   
 Heck and colleagues (2010) evaluated head and neck cancer cases (N=5,642) and 
controls (N=6,069) from eight International Head and Neck Cancer Epidemiology 
(IHNCE) consortium studies that included questions on sexual practices to examine the 
association of the risk of head and neck cancers with sexual practices.  Participants were 
head and neck cancer patients of all ages, sex and race from Argentina, Australia, Brazil, 
Canada, Cuba, India, Italy, Spain, Poland, Puerto Rico, Russia, and the US (Heck et al., 
2010).  Heck and colleagues (2010) note that men may exaggerate in sexual behavior 
studies while women may underreport the number of sexual contacts which should be 
taken into account when analyzing sexual histories.  Wiederman (1997) and Weinhardt et 
al. (1998) support this theory.  
 A history of six or more lifetime sexual partners (OR=1.25, 95% CI, 1.01-1.54) 
and history of four or more oral sex partners (OR=2.25, 95% CI, 1.42-3.58) increased the 
patient’s odds of having OPC (Heck et al., 2010).  Having four or more lifetime oral sex 
partners increased the risk for tonsillar cancer by three-fold (OR=3.36, 95% CI, 1.32-
8.53; Heck et al., 2010).  Point estimates were elevated for base of the tongue cancer with 
two lifetime sexual partners (OR=2.02, 95% CI, 1.19-3.46; Heck et al., 2010).  The risk 
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of having OPC and base of the tongue cancers increased with the change of one sexual 
partner to two (Heck et al., 2010).  There was not, however, a dose-response relationship 
with evaluating an increase in the number of sexual partners (Heck et al., 2010).   
 Increasing age was not a significant factor for development in men (Heck et al., 
2010).  For women, developing base of the tongue cancer was associated with having two 
sexual partners (OR=2.16, 95% CI, 0.79-5.91) and ever having oral sex (OR=4.43, 95% 
CI, 1.06-17.59; Heck et al., 2010).  The age of sexual debut has a significant association 
with oral cavity cancer in women (OR=1.46, 95% CI, 0.19-11.08; Heck et al., 2010).  
The frequency of oral sex did not have a significant association (Heck et al., 2010).  
Therefore, similar risks are present for sexual behaviors and no significant difference 
between the two sexes for 
 outcomes of oral sex (Heck et al., 2010);  
 the number of oral sex partners (Baseman & Koutsky, 2005; Heck et al., 2010); 
and  
 the number of lifetime sexual partners (Baseman & Koutsky, 2005; Gillison et al., 
2008; Heck et al., 2010; Rajkumar et al., 2003; Schwartz et al., 1998).    
A risk for tonsillar cancer in men exists for those who have ever had oral sex, four or 
more oral sex partners, and a younger age of sexual debut (D’Souza et al., 2009; Heck et 
al., 2010).  Men with sexual debut before or at the age of 18 years have a 2-fold risk of 
tonsillar cancer (OR=2.36, 95% CI, 1.37-5.05; Heck et al., 2010).  Having four or more 
lifetime oral sex partners increased the risk for tonsillar cancer by three-fold (OR=3.36, 
95% CI, 1.32-8.53; Heck et al., 2010).   
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 Chaturvedi et al. (2011) noted that studies have shown increased prevalence of 
genital herpes simplex virus 2, herpes simplex virus 1, and genital warts in recent birth 
cohorts in the US (Devesa, Blot & Fraumeni, 1990; Fleming et al., 1997; Hammarstedt et 
al., 2006; Xu et al., 2006).  These diseases are accepted surrogates for oral sex, risky 
sexual behavior, and HPV exposure (Chaturvedi et al., 2011).  Studies have identified a 
tobacco use and alcohol consumption association with risky sexual behaviors including 
multiple sexual partners and less consistent condom use (Heck et al., 2010; Heck, Sell 
and Gorin, 2006; Cook and Clark, 2005; Rigotti, Lee and Wechsler, 2000).   
 D'Souza and colleagues (2009) reported increased risk for HPV oral infection by 
increased lifetime oral and vaginal sex partners as well as open-mouthed kissing in.  
Control cases (n=332) from an outpatient clinic (age ≥18, men and women) and case 
patients (n=210) college aged men (age 19-32) were evaluated with exfoliated oral cell 
samples were collected in ORS and tested for HPV presence.  Both groups had not 
history of cancer (D’Souza et al., 2009).  In the control cases, 4.8% had HPV present 
orally while the case patients had 2.9% of HPV infection detected.  In the control group, 
an independent increased risk was present with the number of lifetime oral sex partners 
(p=0.007) and lifetime vaginal sex partners (p=0.003; D’Souza et al., 2009).  No trend 
was shown in the case group for vaginal sex partners (p=0.44), but existed for number of 
recent oral sex partners (p=0.046) and number of open-mouthed kissing partners 
(p=0.023; D’Souza et al., 2009).  Tobacco users (OR=3.9, 95% CI, 1.2-12.7) had 
elevated risk for oral HPV infection (D’Souza et al., 2009).  In the control group, 
individuals with more than 10 oral sex partners (OR=5.2, 95% CI, 1.1-25) and 25 or 
more vaginal sex partners (OR=3.9, 95% CI, 1.1-15) in their lifetime had elevated risks 
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for oral HPV infection (D’Souza et al., 2009).  The case group showed similar findings 
with 6 or more recent (within 12 months) oral sex partners (OR=7.9, 95% CI, 1.1-59) and 
6 or more open-mouthed kissing partners (OR=17, 95% CI, 1.5-198) after adjustments 
for number of lifetime vaginal sex partners (D’Souza et al., 2009).  To further evaluate 
open-mouth kissing, they found oral HPV infection to be more common in individuals 
(n=59) with 10 or more lifetime kissing partners (p=0.002, 25% versus 0%) and 5 or 
more recent kissing partners (p=0.003, 17% versus 0%; D’Souza et al., 2009).  The study 
finds that measurements of sexual behavior are likely surrogates for oral HPV infection 
(D’Souza et al., 2009). 
 There has been no increased risk association found with oral HPV and men who 
have had sex with a prostitute or an STD (Garrote et al., 2001; Heck et al., 2010; 
D’Souza et al., 2007; Rajkumar et al., 2003).  Heck found no association with oral HPV 
presence and men who have had herpes, genital warts, or a partner with genital warts 
(Heck et al., 2010).  There is a significant association with head and neck tumors and a 
history of same-sex contact including a 5-fold increase risk of tonsillar cancer and a 4-
fold increase risk of mouth cancer, which could be linked to increase smoking habits in 
homosexual males and high passive smoke exposure (Frisch et al., 2003; Heck et al., 
2010; Heck et al., 2006).  
 Tobacco, alcohol, and marijuana risk for HPV oropharyngeal presence.  In 
Schwartz and colleagues’ 1998 study, they also analyzed the participants’ lifetime history 
of tobacco and alcohol use.  To be considered a heavy smoker, the participant had 
smoked 100 or more cigarettes for continuous periods with relatively unchanged habit 
(Schwartz et al., 1998).  To be considered a drinker, the patient had in their life had four 
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or more drinks within each year with no changes in habits over the lifetime (Schwartz et 
al., 1998).  Interviewers inferred about smokeless tobacco (chewing tobacco, snuff, or 
mini-pouches), cigars, and pipes (Schwartz et al., 1998).  These same guidelines have 
been similar to follow study’s definitions. 
 Schwartz et al. (1998), Smith et al. (2004), and Gillison et al. (2000) claimed a 
synergistic effect of heavy smoking, heavy alcohol consumption, and HPV presence.  
Schwartz et al. (1998) and Smith et al. (2004) suggested an additive effect of smoking 
and HPV infection of the oropharynx as well as the oral cavity in those patients who are 
heavy smokers and light alcohol users.  Herrero et al. (2003) found HPV oropharyngeal 
tumors to likely arise in non-smokers verses smokers.  Herrero and colleagues (2003) did, 
however, report a 15-fold increased risk for oral and OPC in current smokers with HPV-
16.  Applebaum et al., (2007), D’Souza et al. (2007) and Gillison et al. (2008) later found 
no statistically significant interaction between HPV, tobacco, and alcohol.  The IARC 
Working Group found no association between HPV OPC and smokeless tobacco use 
(IARC, 2007).   
 The mucosal biological changes in the tissues caused by alcohol consumption 
have been hypothesized to be caused by an increase in the tissues permeability to viral 
infections; an influence in the immune response to HPV; and or causing a chronic 
inflammatory response in epithelium generating free radicals that can damage DNA and 
initiate or progress cancer (Molina et al., 2002; Smith et al., 2004).  Most recently in 
2012, Gillison et al. found an association with smoking and the presence of oral HPV 
(P<0.001).  Alcohol use not associated with oral HPV presence after sexual behavior 
variables were introduced into multivariable models for trend comparison (Gillison et al. 
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(2012).  Study results vary, but there may be some relationship between smoking and the 
presence of HPV. 
 There has not been a significant statistical association found in the HPV-16 
positive head and neck SCC with marijuana use (Hashibe, et al., 2005).  However, it is 
biologically plausible that HPV-positive tumors in the head and neck could be promoted 
by marijuana use due to the molecular epithelium alterations caused by carcinogens in the 
airway similar to the changes caused by tobacco smoke (Gillison et al., 2008).  A virally 
mediated cancer caused by the known immune depressing effects of cannabinoid may be 
more relevant to causes of HPV-16 head and neck cancers (Gillison et al., 2008).  
Marijuana use not associated with oral HPV presence after sexual behavior variables 
were introduced into multivariable models for trend comparison (Gillison et al. (2012). 
 Survival rates of patients with HPV OSCC. Strong evidence supports HPV 
status as an independent prognostic factor for overall survival and progression-free 
survival among patients with oral SCC (Ang et al., 2010; Gillison, et al. 2000; Fakhry et 
al., 2008; Klussman et al., 2009).  Chaturvedi and colleagues recently (2011) found 
evidence of superior survival in HPV OSCC after 15 years as the cause of the improving 
survival rates of all head and neck cancers.  Tonsillar and base of tongue cancer have an 
approximated 25% overall 5-year survival rate (Dahlstrand & Dalianis, 2005; Licitra et 
al., 2006; Ramqvist & Dalianis, 2010; Shiboski et al., 2005). 
 HPV presence and smoking determine the molecular profile of cancer and 
response to therapy (Ang et al., 2010).  Tobacco usage and reduction do contribute to the 
survival in HPV-positive patients (Chaturvedi et al., 2011).  Linguist et al. (2007) and 
Ang et al. (2010) both found that those patients with HPV OSCC who had never smoked 
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had a better prognosis than that of smokers (Ramqvist & Dalianis, 2010).  Clinical 
outcomes and survival have been found to be associated with several factorable 
prognostics factors including  
 tumor stage (Ramqvist & Dalianis, 2010);  
 genetic differences (Ramqvist & Dalianis, 2010); 
 young age (Ang et al., 2010; Ramqvist & Dalianis, 2010); 
 Caucasian (Ang et al., 2010); 
 gender (Ramqvist & Dalianis, 2010; Ukpo et al., 2009); 
 better tumor performance status (Ang et al., 2010); 
 absence of anemia (Ang et al., 2010); and  
 smaller primary tumors (Ang et al., 2010). 
The research group could find no one reason for better response to radiation and 
chemoradiation therapy (Ang et al., 2010).  
  HPV-positive tumors have improved radiosensitivity, which could cause HPV 
status to be considered in the future as a factor to determine best primary treatment 
modalities (Compton et al., 2011).  Patients with HPV-negative tumors and those patients 
who smoke with HPV-positive tumors should be considered for comprehensive neck 
dissection and postoperative radiotherapy and or chemotherapy as both patient types have 
reduced survival rates (Compton et al., 2011).   
 Detection methods for oropharyngeal HPV.  Smith et al. (2004) collected 
exfoliated oral cells from oral rinse samples (ORS) of patients older than 18 years of age 
with newly diagnosed head and neck cancers (N=201) at the University of Iowa 
Hospitals and Health Care or at the Veterans Affairs Medical Center in Iowa City.  These 
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ORS had 30,000 exfoliated cells and the HPV DNA present could have originated from 
HPV-positive tumor cells, any HR-HPV associated infection that caused the development 
of the cancer, or an independent HR-HPV infection (Smith et al., 2004).  The HR-HPV 
DNA most commonly detected in both case patients (19%) and control subjects (10%) 
was HPV-16 (Smith et al., 2004).  HPV-16 was followed by the detection of HPV-18 
(3%), HPV-33 (1%) in the case patients, and HPV-18, HPV-33, and HPV-58 (all <1%) 
in the control subjects (Smith et al., 2004).  These oral infections could be transient, 
similar to those in cervical infections, that have already occurred or they may also have 
tumors that are HPV-positive but may be due to a post-tumor development infection 
(Smith et al., 2004).  This study suggests that assessing through oral exfoliated cells for 
HPV presence at diagnosis but before treatment may aid in identifying the risk of a HPV-
related head and neck tumor (Smith et al., 2004).   
 Smith et al. (2004) detected HPV DNA in 38% of OPC (n=71) with these patients 
having an increased risk of harboring HR-HPV in the exfoliated cells than the oral cancer 
patients (15%, n=130) (adjusted OR=3.6, 95% CI=1.8-7.1).  Furthermore, Smith et al. 
(2004) established a statistically significant association between the presence of HR-HPV 
in biopsied tumor tissues and these virus types in oral exfoliated cells (Smith et al., 2004).  
Individuals with HR-HPV detected in ORS had an increased risk of head and neck cancer 
(OR=2.6, 95% CI=1.5-4.2) compared to HPV-negative patients (Smith et al., 2004).  
Therefore, patients who possess oral exfoliated cells with HR-HPV types have an 
independent increased head and neck cancer risk (Smith et al., 2004).   
 The HPV DNA and specific HPV DNA sequence type is identified from the oral 
exfoliated cells in the ORS by polymerase chain reaction (PCR) (Smith et al., 2004).  
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Oral exfoliated cell rinse tests are less expensive, easier to administer and preserve, 
evaluate a wider variety of HPV types, and are more favorable to patients than blood 
draw (Smith et al., 2004).  Currently OralDNA Labs, Inc. offer OraRisk® salivary DNA 
test for HPV presence that can be administered in the dental setting.  It is still unclear if 
HPV-HR status determined by ORS is predictive of cancer before invasion or progression 
(Smith et al., 2004).  The natural history of oral HPV is still relatively unknown.  
Guidelines for monitoring and treating patients with oral HPV present have not been 
identified.  It is important to note that not all patients with HPV DNA detected in the oral 
mucosa will develop cancerous tumors (Smith et al., 2004).      
 The signs and symptoms of OPC include persistent odynophagia, pain on 
swallowing; dysphagia, difficulty swallowing; dysphonia, defective use of voice; otalgia, 
earache; a feeling of globus, lump in the throat; a neck mass; enlarged lymph nodes or 
unexplained weight loss (Merriam-Webster, 2013; Schlecht, 2012; CDC, 2013).  
Compton et al. (2011) found that 28% of primary tumors will remain undiscovered in the 
oropharynx notwithstanding random tongue base biopsies and tonsillectomy.  These 
lesions are typically undetected early by the patient because they are small, and cause 
little distress until they become more advanced and grow in size (Ramqvist & Dalianis, 
2010).  From their study, Ukpo and colleagues (2009) suggest that lymph nodal 
metastasis may present at an earlier point in oropharyngeal tumor development in patients 
with HPV than with those patients with non-HPV tumors (Ukpo et al., 2009).  Almost 
two-thirds of OPC lesions are diagnosed in stages III and IV, requiring aggressive 
treatment (Silverman, 2005).  Despite receiving a complete workup, up to 5% of patients 
with head and neck cancers will not have the primary tumors discovered (Compton et al., 
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2011).  HPV DNA testing with PCR through oral rinses may aid in detection, prognosis, 
and treatment for patients with head and neck cancers (Compton et al., 2011).   
 Oral cancer education and OCS.  Sankaranarayanan and colleagues (2006) 
studied screening programs for the early detection and prevention of oral cancer 
including a mouth self-examination in South India (N=22.000) and one in Trivandrum 
District, Kerala, South Indian evaluating the efficacy of screening to reduce the incidence 
and mortality of oral cancers also completed by Sankarahanrayana and other colleagues 
in 1995.  The 1995 study found a mortality rate ratio of 0.66 (95% CI; 0.45-0.950) in all 
tobacco, or alcohol users, or users of both in the screening group (n=96,517) versus the 
control group (n=95,536) (Sankaranarayanan et al., 2006).  In high-risk individuals, oral 
visual screenings can reduce mortality and have the potential to prevent at least 37,000 
deaths from cancer worldwide (Sankaranarayanan et al., 2006).  However, there is little 
other information related to the traditional visual and tactile screening examinations’ 
effectiveness in early detection of OPC (Cleveland et al., 2011).  
 The standard of dental hygiene care practices include a complete head and neck 
examination annually (ADHA, 2008; Cotter et al., 2011).  Oral SCC in early stages 
clinically and pathologically is typically identified during non-symptom driven exams by 
dentists, registered dental hygienists, oral and maxillofacial surgeons, and denturists 
(Holmes et al., 2003).  Appropriate treatment is rendered if care is sought from a 
specialist (dentists, oral and maxillofacial surgeon, or otolaryngologist) versus a primary 
care physician (Holmes et al., 2003).  Holmes et al. (2003) found detection practices of 
oral care providers through non-symptom-driven examination, which is most likely to 
occur in a dental office, fosters appropriate treatment and lower stage of diagnosis.  
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Dental care professionals have a legal and ethical obligation in screening all patients for 
oral cancer (Cotter et al., 2011).  Dental hygienists have the opportunity to inform their 
patients and attempt to education the public about the risk factors, signs, and 
ramifications of oral cancer (Ashe, Elter, Southerland, Strauss, & Patton, 2005).   
 Dentists’ and physicians’ perceptions of role in oral cancer education and OCS.  
Applebaum and colleagues conducted a 2003 study surveying Massachusetts’ physicians 
(118, 25.8% response rate) and dentists (274, 58.5% response rate) (2009).  Seventy-
seven percent of the dentist and 52% of the physicians were male with a median 
graduation year of 1982 for dentists and 1985 for physicians (Applebaum et al., 2009). 
Both dentists and physicians believe dentists are qualified to perform oral cancer 
examinations but physicians are less qualified than dentists for these examinations 
(Applebaum et al., 2009).  Dentists generally have regular recare appointments with their 
patients compared to other primary care providers (Applebaum et al., 2009).  This creates 
a consistent opportunity to examine patients for OPC signs and symptoms (Applebaum et 
al., 2009; Victoroff, Lewis, Ellis, & Ntragatakis, 2006).   
 Dentists reported performing oral cancer examinations twice as often physicians, 
with no significant difference in patients or patients seen per week by each provider 
(Applebaum et al., 2007).  However, those patients with the greatest OPC development 
risk will typically go to a physician versus a dentist (Applebaum et al., 2009; Yellowitz, 
Horowitz, Drury, & Goodman, 2000).  According to Holmes, Dierks, Homer, & Potter’s 
(2003) interview of 51 OPC patients, physicians detected the majority of their cancers 
during symptom-driven exams. 
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 Physicians assess oral cancer risk factors more proficiently than dentists when 
taking patient medical histories (Applebaum et al., 2009).  Most physicians are 
knowledgeable about the risk factors associated with oral cancer and management of 
behavior risk factors, such as tobacco and alcohol use, but have poor knowledge of signs 
and symptoms of oral cancer, and feel inadequate identifying it (Applebaum et al., 2007).  
Both physicians and dentists identified SCC as the most common form of oral cancer and 
acknowledge that early oral cancer patients will present asymptomatically (Applebaum et 
al., 2009).  Yet, only 34% of surveyed dentists and 10% physicians identified 
erythroplakia and leukoplakia to be most commonly associated with oral cancer 
(Applebaum et al., 2009).  Thirty-nine percent of dentists and ten percent of physicians 
could identify the two most common oral cancer areas of the mouth (Applebaum et al., 
2009).     
 Applebaum and colleagues’ (2009) noted Maryland and Illinois found similar 
knowledge deficiencies as practice issues compared to their Massachusetts’ study, 
(Applebaum at el, 2009).  Therefore, Applebaum and colleagues’ (2009) findings likely 
exist in other regions of the US and could be extrapolated nationally.  The lack of 
responses (58.5% dentist response rate; 25.8% physician response rate) could indicate 
these findings are higher than analyzed under the assumption that those choosing not to 
respond chose so due to lack of knowledge or feelings of significance of OCS, 
prevention, and detection (Applebaum et al., 2009).   
 In 1998, Ahluwalia and colleagues found that curriculum including oral cancer 
information and examination, in 86 U.S. medical schools, was brief and not thorough.  
Later studies have identified the need for improvement of education for health care 
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providers about oral cancer risk factors and detection of early mucosal changes, 
particularly ulcerative lesions, leukoplakia, and erythroplakia (Carter & Odgen, 2007a; 
Carter & Odgen, 2007b; Carter et al., 2009; Patton, Elter, Southerland, & Strauss, 2006).  
Recent graduates (after 1992), both medical and dental, had a five-fold greater likelihood 
of scoring higher on oral cancer knowledge surveys than earlier graduates (1972) 
(OR=5.0; 95% CI, 1.2-19.7) (Applebaum et al., 2009; Patton, Epstein, & Kerr, 2008).  
However, Applebaum and colleagues (2009) recommends inclusion of comprehensive 
oral examinations in the curriculum of medical schools.  Dentists and physicians are both 
in support of education advancement of oral cancer (Applebaum et al., 2009; Canto, 
Horowitz, Drury, & Goodman, 2002; Horowitz et al., 2002; McCunniff, Barker, G., 
Barker, B., & Williams, 2000).  Adding additional courses in diagnosis and management 
of oral cancer may include risk factor screening; behavior modification counseling; oral 
cavity physical examination; and review of guidelines for specialist referral for biopsy, 
definitive diagnosis, and or treatment (Applebaum et al., 2009). 
Nurses’ perceptions of role in oral cancer education and OCS.  In the United 
Kingdom, Carter, Harris, Kavi, Johnson, & Kanatas (2009) conducted a study of nurses 
(N=121), over 80% (n=>97) felt examining a patient’s mouth upon hospital admission is 
important.  Seven percent of nurses would examine the floor of the mouth, but 74% 
(n=90) would exam the tongue for potential malignant changes (Carter et al., 2009).  
Only 49% (n=59) of nurses regularly examine the oral cavity for cancer (Carter et al., 
2009).  Less than 25% (n=<31) of nurses identified ulceration as the most common sign 
of oral cancer (Carter et al., 2009).  Less than 5% (n=7) of nurses identified erythroplakia 
as a sign of oral cancer (Carter et al., 2009).  When questioned on oral cancer risk factors, 
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60% (n=<73) identified smoking, less than 30% (n=37) identified alcohol, and other risk 
factors were identified less (Carter et al., 2009).  Nurses who had regular dental care did 
not have a significant improvement in clinical sign identification (p=0.478; Carter et al., 
2009).     
 Dental hygienists’ perceptions of role in oral cancer education and OCS.  In 
Bigelow et al.’s 2007, qualitative study of 16 registered dental hygienists in North 
Carolina gathered qualitative data related to dental hygienists’ view on oral cancer 
control with focus on non-HPV cancers.  The majority of dental hygienists reported 
performing OCS on every patient by both dentist and dental hygienist.  The sample was 
composed of 2 small focus groups with 8 dental hygienists in each group.  Percentages 
and response numbers were not documented.  Registered dental hygienists felt most 
dentists perform an examination of intra-oral mucosa but felt it was unusual for a dentist 
to perform an entire head and neck exam (Bigelow et al., 2007).  The dental hygienists 
had strong feelings regarding their position in assisting an increased awareness of patient 
communities and helping promote change in these community members (Bigelow et al., 
2007).  These dental hygienists expressed the importance of relationship development of 
trust between patients and providers to increase patients’ perceived value of the dental 
hygiene appointments and procedures (Bigelow et al., 2007).  Patients are more open 
with dental hygienists about their [patients’] perception of change (Bigelow et al., 2007).  
These dental hygienists placed significant importance on patient education in their role as 
oral health care professionals (Bigelow et al., 2007).   
 In Bigelow’s study, the interviewed dental hygienists felt their role was not to 
diagnose cancer (Bigelow et al., 2007).  Dental hygienists did not feel confident with 
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their level of training to make a differential diagnosis for oral malignancy, but felt their 
role is to recognize normal and abnormal tissues and initiate a referral for differential 
diagnosis (Bigelow et al., 2007).  These dental hygienists feel clinical data for future 
comparison was critical and that intraoral pictures shown to patients helped them 
recognize lesions (Bigelow et al., 2007).  The dental hygienists identified: lack of 
appointment time for adequate health history assessment including assessment of alcohol 
and tobacco use; lack of dentist employer support; and the dentist not encouraging 
referral for biopsies as reasons for not conducting a OCS (Bigelow et al., 2007).  Dental 
hygienists felt showing patients genuine concern and care about the patients’ oral health 
is the most important role they can play in patient care (Bigelow et al., 2007).  
 In a study by Cotter, McCall, Schneiderman, De Wald, & Campbell (2011), 
45.8% (n=140) dental hygienists in Texas (N=306) self-report always performing OCS 
for patients (2011).  One-third of those completing the OCS are doing so regardless of the 
patient’s age (Cotter et al., 2011).  Approximately half of Texan dental hygienists, 49.9% 
(n=153), reported never routinely perform extraoral palpation exams during initial or 
recall appointments (Cotter et al., 2011).  Significant association was found between the 
dental hygienists’ confidence level of intraoral and extraoral examinations and 
performing OCS (p=0.16, p<0.001); thus, if dental hygienists were confident performing 
these exams, they were more likely to complete them during the appointments  (Cotter et 
al., 2011). 
 Cotter et al., (2011) also found those dental hygienists who had a history of 
identifying positive suspicious lesions were more likely to complete the OCS during 
appointments (Cotter et al., 2011).  Dental hygienists practicing 5 or more years always 
 42 
DENTAL HYGIENISTS AND HUMAN PAPILLOMAVIRUSES     
 
performed OCS 50% of the time; compared to dental hygienists practicing less than 5 
years, always completing OCS 25% of the time (p=0.15, p<0.007) (Cotter et al., 2011).  
The Texas dental hygienists, in Cotter and colleagues’ study (2011), reported reasons for 
not completing OCS during appointments as: the dentist does it; it takes too much time; 
and feeling not adequately trained.  The more often dental hygienists attend an OCS 
continuing education course, the more likely they are to perform an OCS (p=0.22, 
p<0.001) (Cotter et al., 2011).    
 When knowledge was tested for oral cancer and risk factors, the Texan dental 
hygienists’ median score was 52.6% with a range from 14% to 95% (Cotter et al., 2011). 
Only 23.8% of the respondents correctly identified the most common site for HPV as the 
posterior (n=73).  When asked to identify the site of the most increased risk for oral 
cancer developed from HPV, only 14.2% (n=42) identified the oropharynx (Cotter et al., 
2011).  When asked if male or females had the risk for oral HPV, 14.2% (n=43) 
identified males as having the highest risk (Cotter et al., 2011).  These low outcomes 
suggest the need for continuing education programs focused on oral cancer risk factor 
awareness, specifically: HPV, age, lesions appearance, and common lesion location 
(Cotter et al., 2011).   
 Dentists’ and dental hygienists’ perceptions of educating patients about oral 
HPV and associated risk factors.  An exploratory study was completed in 2009 in by 
Daley et al. to determine oral health professionals’ knowledge about HPV and OPC, 
attitudes, and perceived role in discussing HPV OPC and vaccination options with 
patients or parents of minors (Daley et al., 2011).  There were three focus groups ranging 
from 4-13 participants in each group including 17 dentists and 21 dental hygienists for 
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the total sample (N=38) (Daley et al., 2011).  The majority of the participants were 
Caucasian women age 23 to 66 years (Daley et al., 2011).  Using qualitative design, 
audio recordings were used to analyze the response for recurring themes and diversity in 
responses (Daley et al., 2011).   
 Participants reported knowledge ranging from lacking to having some knowledge 
of the details of the HPV associated OPC as well as information about HPV vaccinations 
(Daley et al., 2011).  Daley et al. found the groups felt that emerging HPV-positive oral 
cancer information was creating a shift in the standard of practice towards screening 
every patient for oral cancer (Daley et al., 2011).  Because of this shift, participants felt 
their associated professional organizations should provide recommendations to manage 
screening standards for OPC related to HPV (Daley et al., 2011).  When addressing risk 
factor assessments with their patients, the groups’ attitudes ranged from discomfort to no 
concern (Daley et al., 2011).  Respondents made the connection that OHP already discuss 
sensitive subjects with patients including domestic violence, drug use, or eating disorders 
(Daley et al., 2011).   
 One concern participants identified was the constraints of the physical 
environment of dental operatories without doors within the dental office (Daley et al., 
2011).  Male dentists of the group worried that addressing sexual histories and behaviors 
could cause accusations of sexual harassment or inappropriate behavior (Daley et al., 
2011).  Subjects in the group alluded to gender roles and noted the dental hygienists, who 
are typically female, were better positioned to engage in sensitive discussion with both 
men and women both for themselves and their children (Daley et al., 2011).    
 44 
DENTAL HYGIENISTS AND HUMAN PAPILLOMAVIRUSES     
 
 Participants were reluctant to discuss vaccinations due to the lack of research 
supporting the vaccines ability to prevent oral cancers caused by HPV (Daley et al., 
2011).  Overall, participants suggested information coming from their professional 
organizations would relieve the discomfort of addressing risks associated with sexual 
behaviors (Daley et al., 2011).  Uncertainty arises in regards to practice standards 
because; in addition to the traditional risk factors including older age, male gender, and 
tobacco use, no new guidelines have been developed to incorporate evolving risk factors 
such as HPV (Daley et al., 2011).   
 This study only represented a small sample from Florida so results cannot be 
generalized beyond the pool (Daley et al., 2011).  There are no quantitative data available 
for comparison.  Women are commonly over-represented in voluntary focus group 
samples so study data cannot be interpreted as having any inferential meaning (Daley et 
al., 2011).  This study lacked theoretical framework, however, the responses provided 
serve as a foundation to further research such as the focus of this thesis (Daley et al., 
2011).     
 Cervical HPV education modalities.  Source information about HPV and 
cervical cancer screening include friends and family, health education classes (university 
students), and mass media, including magazines, newspapers, radio, television, and books 
(Anhang et al., 2004; Gerhardt et al., 2004; Yacobbi et al., 1999).  In relation to cervical 
cancer, media has failed to effectively convey the difference of low- and high-risk types 
of HPV or correct levels of HPV risk perception therefore the medical community is 
called on to fill the informational gaps (Anhang et al., 2004).   
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 In Person County, North Carolina, Crates and colleagues (2009) surveyed 138 
African American and Caucasian women from, found statistics showing 24% of African 
American women have heard of HPV, while 57% of Caucasian women had heard of the 
virus.  Of the whole sample, only 20% (n=27.6) of these women, of both races, had heard 
of the availability of vaccines for HPV (Crates et al., 2009).  African American women 
were less likely to think a serious threat could develop for themselves or their daughter(s) 
if infected by HPV (Crates et al., 2009).   
 Media has the ability to reach populations through creating blanket awareness of 
HPV basics including the mode of transmission, prevention, treatment, and the risk of 
cancer (Anhang et al., 2004).  Medical health care providers interacting with patients in 
relation to cervical cancer screening and HPV DNA testing face common challenges 
including 
 patients are not generally knowledgeable about HPV; 
 non-clinical sources of HPV information provide incomplete backgrounds; 
 several complex options exist for cervical cancer screening; and 
 limited time is available for patient counseling (Anhang et al., 2004). 
 Two way communication between the patient and the clinician to promote shared 
decision making requires clinicians to provide background characteristics of available 
screening tests, the benefits and risks of each, the potential effects on the patient’s 
psychological and social well-being, and the technical information (Anhang et al., 2004).  
In turn, the patients express their beliefs and anxieties about HPV, their existing 
knowledge of screening tests, and their preferred option for screening (Anhang et al., 
2004).   
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 For cervical cancer, Monk and Wiley (2003) recommend during patient education 
sessions about HPV and HPV testing to emphasize the facts that HPV is common and 
sexually transmitted.  They further encourage clinicians to explain how most women with 
HPV will not develop cervical cancer and the most common prognosis for HPV is 
clearance from the body without treatment (Monk & Wiley, 2003).  Lastly, they advise 
communicating the purpose of a Pap test is to detect HPV-related lesions in the cervix 
suggestive of precancerous or cancerous conditions, and that most women who test 
positive for HR-HPV will not be diagnosed with cervical cancer or a precursor on further 
evaluation (Anhang et al., 2004).  Dental hygienists could use these education methods to 
provide the facts to dental patients about oral HPV.  If guidelines are established for 
testing for oral HPV status, these patient education modalities could be referenced in 
educating patients will positive oral HPV presence. 
Problem as Developed from Theories and Research 
 The studies reviewed all indicate a lack of clear direction for dental hygienists in 
the education about oral HPV.  Daley and colleagues’ Florida study (2011) lacks sample 
(N=38) size to represent the entire nation, yet study results identified the need for 
direction for dental health care providers to take on the role of educating patients about 
the risk of oral HPV.  No studies have been published assessing perceptions of dental 
hygienists in their role as educator about HPV OPC and the risks.  The authors of the 
studies’ reviewed in this chapter support professional organizations, such as the ADHA 
and the American Dental Association, continued development recommendations and 
guidelines to assist dental professionals, including dentist and dental hygienists, in 
approaching the risk factors, prevention, and treatment of HPV OPC.  This thesis 
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continued from Daley et al. (2011) to target dental hygienists on a larger scale across the 
nation.  This thesis’ results can assist ADHA and dental hygiene educational programs to 
develop guidelines meeting the needs of practicing dental hygienists.  
 Recommendations.  Many of the researchers have recommended the evaluation 
of HPV vaccination for possible oral HPV infection control and prevention of OSCC.  
Need existed for additional HPV vaccine information pertaining to potential provisions, 
risks, and benefits for patients (Fang et al., 2010).  In his 2012 editorial in the Journal of 
the American Medical Association, Hans P. Schlecht, MD recommended clinicians stress 
oral sex barrier protection, and practice vigilantly to detect signs and symptoms of OPC 
through thorough head and neck evaluations.   
 Cleveland et al. (2011) recommended dental health care personnel become 
knowledgeable about HPV and OPC.  Researchers suggested professional health care 
associations take leading roles to appropriate screening guidelines for oral HPV detection 
methods while promoting interdisciplinary prevention, detection, and treatment (Anhang 
et al., 2004; Applebaum et al., 2009; Bigelow et al., 2007; Cleveland et al., 2011; Cotter 
et al., 2011; Daley et al., 2011).  The development of state models to help increase 
awareness among dentists and dental hygienists regarding the importance of risk factor 
assessment and regular performance of OCS for every patient have been recommended 
such as mandatory oral cancer continuing education for licensure renewal similar to 
requirements for Cardiac Pulmonary Resuscitation (Bigelow et al., 2007; Cotter et al., 
2011).  Cotter and colleagues (2011) recommended oral cancer continuing education 
courses also address legal aspects of OCS performance as well as documentations and 
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referrals including Current Dental Terminology of the American Dental Association 
billing codes that would create a mechanism for billing and documentation for OCS.  
 Dental hygiene programs could incorporate clinical rotations for dental hygiene 
students to witness OPC patients affected by chemotherapy and radiation treatments.  
Dental hygiene programs can focus more on oral pathology curriculum as well as 
increase emphasis on OCS to reduce new graduates’ inclination to bypass OCS to save 
appointment time for debridement (Cotter et al., 2011).  Applebaum and colleagues 
(2009) suggested increasing education opportunities for both dentists and physicians to 
address oral cancer prevention, OCS, and early detection.   
Summary 
 The research has defined that two types of oral cancer now exist; those caused by 
tobacco and alcohol use, and those with oral HPV present (D’Souza et al., 2007; Fakhry 
et al., 2008; Heck et al., 2010; Gillison et al., 2000; Klussman et al., 2009).  Those oral 
cancers caused by tobacco and alcohol use are declining across the US (Cleveland et al., 
2011; Herrero et al., 2003; Shiboski, Schmidt, & Jordan, 2005).  The oral cancers in the 
oropharynx with HPV present are rising across the nation (Cleveland et al., 2011; Herrero 
et al., 2003; Shiboski, Schmidt, & Jordan, 2005).  Specifically, they are rising in 
Caucasian men less than 60 years old (Chaturvedi et al., 2008; Ryerson et al., 2008).  
Patients coming into the dental offices assume dental professionals not only examine for 
the presence of tooth decay and periodontal disease, but head and neck cancers.  In one 
small US study, only 34% of people (N=93) identify HPV as a risk for OPC (Dodd, 
Riley, & Logan, 2012).  The question remains: Who should be approaching oral HPV and 
discussing the risk of developing oral cancer with patients? 
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Methodology 
 
Design  
The intent of this study was to determine if dental hygienists are aware of the 
risks surrounding oral HPV and cancer; and if so, are they discussing the associated risk 
with their patients.  Growing research supports the presence of HPV in OPC 
(Applebaum, Ruhlen, Kronenberg, & Peters, 2007; Chaturvedi et al., 2011; D’Souza et 
al., 2007; Gillison et al., 2000; Gillison et al., 2008; Hansson et al., 2005; Herrero et al., 
2003; Schwartz et al., 1998; Smith et al., 2004).  Dental hygienists may or may not be 
aware of this link, the mode of transmission, and the associated risk factors.   
The design of this study was qualitative in survey form to describe feelings, 
perceptions, and attitudes of dental hygienists about their knowledge about oral HPV and 
its associated risks for OPC.  After approval was granted from Eastern Washington 
University (EWU) Institutional Review Board (IRB), each dental hygienist from the 
selected states received an introductory email explaining 
 the study;  
 verification of approval by the EWU IRB; 
 information about the participant prize drawing; and 
 the web link to survey (see Appendix A).   
The online survey program, Survey Monkey®, was used to post the survey.  Quantitative 
methods were applied to determine if there were correlation between these perceptions 
and current screening practice trends (Glatthorn and Joyner, 2005).  The survey intended 
to answer the following research questions: 
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1. Are dental hygienists knowledgeable of the risks of oral HPV?   
2. Are dental hygienists in the United States educating their patients about the 
risk of OPC caused by HPV? 
3. Are dental hygienists screening patients with intraoral screenings and risk 
assessment tools to determine their risk for oral HPV? 
4. Why are dental hygienists deciding to discuss or not discuss HPV OSSC? 
5.  Why are dental hygienists opting to discuss or not discuss HPV vaccination 
availability with their patients? 
The research intended to provide relevant data to the dental and medical communities.  If 
HPV prevalence trends continue to increase, it will be important for the dental hygienist 
to understand their role in educating patients about risks associated with oral HPV in 
order to increase patient awareness. 
Variables.  Questions asked using a Likert scale were the controlled variables of 
the survey.  These controlled variables included 
 level of knowledge dental hygienists have in discussing HPV and oral 
cancer; 
 ability to identify mode of transmission, risk factors and most likely tumor 
locations;   
 frequency that dental hygienists discuss the risk of oral cancers 
development with HPV present; 
 frequency that dental hygienists discuss the mode of transmission for oral 
HPV with their patients; 
 frequency that dental hygienists perform intraoral screenings on patients; 
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 frequency that patients complete a risk assessment for oral cancer; 
 question types included on the risk assessment if applicable, specifically 
sexual history and HPV history; 
 level of comfort dental hygienists have discussing oral HPV with their 
patients; and 
 likelihood a dental hygienist would recommend HPV vaccination 
consideration to a patient, a parent, or legal guardian of a minor child. 
Uncontrolled variables were the response rate as well as participant responses because the 
respondents could choose to respond and answer based on their own personal practice, 
knowledge, and beliefs.     
 The independent variables were the region of location, rural or urban location, 
age, gender, education level, type of practice, and years in practice for the responding 
dental hygienists.  Frequency of intraoral examination and risk assessment were the 
independent variables pertaining to each individual dental hygienist.  Other independent 
variables included dental hygienists’ knowledge about oral cancer, particularly HPV 
OPC, and the responses dental hygienists provided regarding barriers to educating 
patients, patient acceptance of education, and attitude of belief/disbelief that oral HPV 
education should be provided by dental hygienists.   
Research method or design.  The qualitative survey included 26 questions 
formatted into sections including demographics, practice characteristics, knowledge, and 
explanations.  For descriptive and comparison purposes, demographics were collected.  
These included location of practice (state, rural or urban), age range, gender, education 
level, practice setting type, and years in practice of respondent.  Urban was defined as a 
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minimum of 50,000 people per territory while rural was defined as less than 50,000 
people per territory (United States Census Bureau, 2013).  There were seven 
demographic questions. 
Dental hygienists’ knowledge about OPC and HPV were also examined (5 
questions).  Current OCS (2 questions) and risk assessments (3 questions) trends, and 
feelings related to dental hygienists’ role in HPV OPC education (4 questions) were 
addressed in the characteristic questions’ section.  A Likert scale was provided for the 
characteristic ranking of frequency, likelihood, or feeling.  Three open-ended questions 
were included at the end of the survey to elicit perceived barriers in comfort of 
addressing these topics with patients as well as recommendation of who should provide 
this information to patients.   
 Willingness to complete the survey implied consent.  The PI emailed the 
Washington state dental hygienists directly, while contacts in Connecticut, Oklahoma, 
Mississippi and Wisconsin forwarded the email to the state’s members of the Dental 
Hygienists’’ Association.  For those Washington state dental hygienists who did not reply 
to the PI to be entered into the state drawing, an email was resent in two weeks.  The 
survey was resent again three weeks from the initial email, for three opportunities to 
participate.  The dental hygienists in Connecticut, Oklahoma, Mississippi, and Wisconsin 
were sent all three of the survey opportunities regardless if they replied to be entered into 
their state’s drawing. The dental hygienists completing the survey were informed of a 
random drawing for five $25.00 iTunes gift cards.  One gift card winner was selected per 
state.  Participants could enter this drawing by simply sending a reply email to the 
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primary investigator (PI).  This ensured anonymity while completing the survey.  Gift 
card winners were drawn and notified after the survey was closed.      
Description of Setting 
This research was conducted via the Internet through a survey website link to 
Survey Monkey®.  Those individuals participating in the study were from Oklahoma, 
Wisconsin, Connecticut, Mississippi, and Washington. 
Sample 
 The states designated to represent five regions in the US were: Oklahoma 
(Southwest), Wisconsin (Midwest Region), Connecticut (Northeast Region), Mississippi 
(Southeast Region), and Washington (West Region) were conveniently selected.  Dental 
hygienists included on each selected state association’s email list were emailed the survey 
link to Survey Monkey®.  Participation was on a volunteer basis. 
Human subjects protection.  Human subjects protection was obtained from 
EWU.  The human subjects of this research were those who willingly completed the 
online survey.  The identity of the respondents was anonymous through Survey 
Monkey® privacy settings.  Survey Monkey® required a secured user name and 
password to access the data.  The data was imported to and organized on a Microsoft 
Excel® spreadsheet.  This data is stored on the PI’s password protected personal 
computer. 
Sampling plan.  The survey was sent to all dental hygiene members on the 
selected state’s dental hygienists’ association’s emailing list.  If a dental hygienist was a 
member but did not have an email listed, they were not included in the sample.  
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Respondents could only answer the survey once based on the IP address from which they 
took the survey.  
Sample size.  Statistical significance was achieved with 428 licensed and 
practicing dental hygienists responding to the email and participating in the survey.  The 
research achieved ± 5% for precision level and confidence level of 95%. 
Data Collection 
Methods.  Each selected state’s dental hygienists’ association was contacted to 
request email addresses for all licensed practicing dental hygienists within the state 
(Oklahoma, Wisconsin, Connecticut, Mississippi, and Washington).  Survey data was 
collected from Survey Monkey® at www.surveymonkey.com.  The email link was 
emailed a total of three times to each dental hygienist on the emailing list over a four-
week period.  A statistician, in collaboration with the PI, statistically analyzed the data.  
Quantitative methods were used to evaluate the views and opinions of dental hygienists.  
Participants were emailed a thank you letter and the results of the study.  Additionally, 
the participants received notification that they had been entered into a drawing for one of 
five $25.00 gift cards from iTunes.   
Instruments.  The survey was created on www.surveymonkey.com.  From the 
PI’s graduate student email account, all email recipients were sent the Survey Monkey® 
survey link.  The survey gathered demographic data (Questions #1-7) including region of 
practice, population density of practice city or town, age, and gender.  Information 
pertaining to the dental hygienists’ education level, current practice setting, and years in 
practice was also collected for analysis.  A Likert scale for 19 questions, as well as three 
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open-ended questions at the end of the survey, surveyed the respondents for current 
practice, perceptions, and knowledge of oral HPV (see Appendix B).   
Dental hygienists were asked about the frequency in which they perform intraoral 
screenings and risk assessments for their patients in Questions #8-10.  The available 
response choices were: on every patient, rarely, some of the time, and never.  If 
respondents reported providing intraoral screenings and risk assessments some of the 
time, further information was sought including the reasons/rationale dental hygienists 
decide to do so.  Clinicians were asked to identify the reason they most likely completed 
the intraoral screening or reason in the following question.  The reasons provided were:  
 time at the end of the appointment; 
 finding suspicious tissue; 
 if the patient has concern;  
 the patient has a history of or uses tobacco; 
 the patient has a history of or uses alcohol use;  
 the patient has a history of or uses marijuana; or 
 has a history of HPV or has the virus.  
If clinicians did complete a risk assessment for their patients, Question # 12 inquired 
about the type of risk assessment questions including tobacco, alcohol, and marijuana 
history and use frequency, sexual history, and HPV history. 
 The respondents were asked how frequently they discussed the risk of oral HPV 
cancers in Question #13.  They were given the same response options as listed for the 
previous questions pertaining to intraoral screening (Question #9) and risk assessment 
(Question #11) completion frequency.  If respondents were discussing the risk of oral 
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HPV cancer with their patients, the following questions were asked of frequency 
discussing oral HPV mode of transmission.  The same frequency responses for Questions 
#9 and #11 were provided.  The same format was used to ask respondents about how 
frequently they discussed the mode of transmission of oral HPV in Question #15 and #16.   
 Questions #17-21 collected knowledge data.  The respondents were asked about 
their self-perceived knowledge level.  Response options included very knowledgeable, 
somewhat knowledgeable, knowledgeable, unknowledgeable, and very unknowledgeable.  
The respondents were asked to identify the rate of occurrence with the incidence of oral 
HPV in OPC (Question #18) as declining, rising, no change, or no prevalence.  The 
following question (Question #19) asked the respondent to identify the mode of oral HPV 
transmission as sexual contact, oral sexual contact, kissing, sharing of eating utensils, 
unknown, or history of genital HPV.  Question #20 asked the respondents to identify the 
patients at the highest risk for HPV OPC.  Respondents could select more than one of the 
following options: men, women, age 20-55, age 55+, heterosexuals, homosexuals, 
Caucasian, African American, or Mexican and Native American.  Lastly (Questions #21), 
respondents were asked to identify the most common location of oral cancer caused by 
HPV as the hard palate, dorsal surface of the tongue, lateral border of the tongue, the 
vestibules, lingual tonsils, floor of the mouth, or the palatal tonsils. 
 The final Likert questions (Question #22 and #23) asked about the respondent’s 
feelings of comfort in addressing the risk of oral HPV cancers and HPV vaccine options 
with patients.  When asked about comfort of discussing the risk of oral cancer caused by 
HPV, respondents were given the options of very comfortable, comfortable, fairly 
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comfortable, uncomfortable, and very uncomfortable.  The respondents were asked about 
likelihood of recommending HPV vaccination as the final Likert question. 
 Three open-ended questions completed the survey.  Respondents had the option of 
providing insight if they felt uncomfortable discussing HPV with their patients.  In the 
first open-ended question (Question #24), they could identify barriers that may prevent 
them from feeling comfortable discussing oral HPV with their patients.  Question #25 
asked the dental hygienist if they felt patients would be receptive to oral HPV education 
in the dental setting.  Lastly (Question #26), the respondents had the opportunity to state 
if they felt dental hygienists are in a role to provide oral HPV education to their patients, 
and if not, which health care provider they felt should be providing this education (see 
Appendix B). 
Reliability and validity.  Evaluation of the survey instrument to determine 
reliability and validity was achieved through appraisal by thesis committee and all 
graduate faculty in the dental hygiene department.  The thesis committee was comprised 
in part by dental hygiene educators who hold Master's degrees, with one holding a 
doctoral degree.  All members were well-versed on HPV concepts.  
The questionnaire was presented and pretested on a sample of EWU dental 
hygiene program alumni and feedback was incorporated into the final questionnaire to 
minimize question wording ambiguity and response bias (Cooper & Schindler, 2011).  
The questions were deemed to possess face and content validity by the PI and thesis 
committee members (Zikmund, Babin, Carr & Griffin, 2010).  Face validity of the 
measures was established by the agreement between the PI and thesis members that the 
questions and scales logically reflected the concepts being measured.  Further, the PI and 
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thesis committee members determined the measures included in the questionnaire cover 
the domain of interest and thus meet content validity.   
Procedure.  Following EWU IRB approval, the PI requested emails of current 
licensed practicing members of the dental hygienists’ associations from the states of 
Oklahoma, Wisconsin, Connecticut, Mississippi, and Washington.  Every dental hygiene 
member on the association’s email list for Washington was emailed from the PI’s EWU 
graduate student’s email account.  The presidents of the dental hygienists’ associations 
for Oklahoma, Wisconsin, Connecticut, and Mississippi were emailed the link, which 
they forwarded to their membership email lists.  The first email sent included the  survey 
link and a cover letter emphasizing confidentiality, significance of study, approval of 
EWU IRB, and opportunity to participate in a drawing.  The drawing was for one $25 gift 
card from iTunes for each selected state respondents.  To be eligible for the drawing, the 
respondent sent a reply email to the PI to notify of survey completion and ensure the 
respondent remained anonymous through the survey.   
Two weeks after the initial email, another email was sent to all respondents in 
Washington and the presidents of the other four states.  Washington recipients who had 
emailed the PI to be entered into the drawing were removed from the email list.  The 
following week, a third email was sent in the same manner.  The survey remained open 
for the remaining seven days and closed on the eighth
 
day resulting in the study survey 
being conducted four weeks.  Participants could not be identified by the information they 
provided on the survey regardless when they completed it.  Oklahoma’s survey period 
started a week later and therefore, ended one week later than the other states due to a 
delay in email release. 
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Statistical Analysis 
Survey results were collected through Survey Monkey® and transferred to a 
Microsoft Excel® spreadsheet.  Collection was completed with Excel® for transfer to the 
statistical program, Statdisk®, for analysis for the statistical descriptions.  Descriptive 
statistics were analyzed for common trends based on age, gender, region location, town 
population density, education level, practice setting, and years in practice.  The chi-
square test (χ2 test) was used for qualitative comparison of demographic classifications 
and question responses.  The independence tests, Goodness-of-Fit and Contingency 
Analysis, evaluated for existing relationships between the different variables within the 
survey.  Expected frequencies based on proportions of the responses were calculated for 
the statistical analysis of the data. 
The survey results further determined the knowledge level of the respondents 
based on their answers to questions related to oral HPV risk factors and common HPV 
OPC locations.  Knowledge of oral HPV was compared among region location, town 
population density, age, gender, education level, practice setting, and years in practice.  
Responses for incidence and mode of transmission were analyzed for statistical 
significance.  Responses for populations at risk and tumor location identification were 
reviewed for trends as they questions allowed multiple answer selection.  
For those dental hygienists including an oral cancer risk assessment in their dental 
history collection, comparisons were made for those who included sexual history 
questions and questions about history of HPV.  The results were compared against the 
independent variables.  Years in practice of the respondents as well as the geographic 
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location of the dental practice were specifically evaluated to determine current trends in 
intraoral screenings, risk assessment, and patient education.   
Comfort in oral HPV education was compared against region location, town 
population density, age, gender, education level, practice setting, and years in practice.  
The frequency of discussing the possible modes of oral HPV transmission was also 
evaluated against all independent variables for statistical significance.   
The open-ended question responses were gathered to provide information on 
possible barriers to patient education including clinician comfort of topic and opinion of 
patient.  Respondents also had the opportunity to express if they believed oral HPV 
education should be included in their role as a dental hygienist and if not, which health 
care professional should be providing this information.  The PI looked for recurring 
themes in the open-ended questions.  Using grounded theory technique, data were 
analyzed and recurring themes were found to explain the phenomenon being studied.   
Lastly, HPV vaccination education was included in questioning about the role of 
dental hygienists in educating patients about HPV.  This data was reviewed for 
duplication to identify if recurring trends existed.   
Summary 
 This study provides the dental community with empirical data indicating if 
patients are being educated about oral HPV by dental hygienists during dental hygiene 
appointments.  The qualitative research using quantitative methods allowed the PI and 
statistic consultant to determine if a need exists to improve dental hygienists’ comfort 
and confidence in addressing oral HPV with their patients.   
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Results 
 
Introduction 
 
This qualitative design used a Likert style survey to collect data to describe 
feelings, perceptions, and attitudes of dental hygienists about their knowledge of oral 
HPV and its associated risks for OPC.  The research analyzed the dental hygienists’ 
responses from the survey to determine if relationships exist based upon their 
demographics and knowledge, comfort, and likelihood to discuss oral HPV with patients.  
The results sought to answer the following survey questions: 
1. Are dental hygienists knowledgeable of the risks of oral HPV?   
2. Are dental hygienists in the United States educating their patients about the 
risk of OPC caused by HPV? 
3. Are dental hygienists screening patients with intraoral screenings and risk 
assessment tools to determine their risk for oral HPV? 
4. Why are dental hygienists deciding to discuss or not discuss HPV OSSC? 
5.  Why are dental hygienists opting to discuss or not discuss HPV vaccination 
availability with their patients?  
The survey included open-ended questions in addition to the survey responses, which 
have been evaluated for trends and reported in this chapter.  The data was statistically 
analyzed using chi-square test of independence (Goodness-of-Fit Test) and a chi-square 
test of association (Contingency Analysis) to test if relationships existed between the 
variables of the survey.  The analysis tested for significance by a p-value of less than 0.05 
being statistically significant.  
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Description of Sample 
Four thousand, eleven dental hygienists from Connecticut, Mississippi, 
Oklahoma, Washington, and Wisconsin were emailed the introduction email letter 
including the survey link to Survey Monkey® for the opportunity to volunteer to 
participate.  Four hundred twenty-eight dental hygienists (N=428) participated in the 
survey providing a 10.67% response rate.  One survey was removed from the sample as 
no responses were submitted as all survey questions skipped.  One participant answered 
and mailed a printed survey, which was entered electronically to Surveymonkey.com by 
the PI.  Respondents were permitted to skip questions; therefore, the respondent sample 
varies per question.  Due to the small sample size, statistical analysis was difficult when 
comparing all response options for some questions because some response options had 
frequencies less than 5.    
The sample was predominantly female (n=421, 98.36%) dental hygienists of ages 
51 or older (n=160, 37.38%) with Bachelor’s of Science degrees (n=209, 48.83%).  The 
majority of the respondents had practiced for 15 or more years (n=194, 45.33%).  Most 
of the respondents practiced in an urban setting (n=285, 66.59%) in a private practice 
clinic (n=362, 84.58%).  Most of the dental hygienists practiced in Washington state 
(n=317, 74.07%).  Table 1 describes the demographical information of the survey sample 
by each state (Table 1).  
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Table 1 
Demographic description of survey sample 
Sample Size 
(N=4,011) 
Connecticut  Mississippi Oklahoma  Washington  Wisconsin  
Response Rate n % n % n % n % n % 
Response  51 54.26 14 14.29 33  6.63 317 10.63 13 3.82 
City Population 
Urban 
Rural  
 
30 
21 
 
58.82 
41.18 
 
8 
6 
 
57.14 
42.86 
 
20 
13 
 
60.61 
39.39 
 
218 
99 
 
68.77 
31.23 
 
9 
3 
 
69.23
30.77 
Age (in years) 
≤30  
31-40 
41-50 
≥51  
 
19 
9 
6 
17 
 
37.25 
17.65 
11.76 
33.33 
 
2 
5 
2 
5 
 
14.29
35.71
14.29
35.71 
 
8 
9 
5 
9 
 
24.24
27.27
21.21
27.27 
 
57 
86 
52 
122 
 
17.98
27.13
16.40
38.49 
 
1 
2 
3 
7 
 
7.691
5.38 
23.08
53.85 
Gender  
Female 
Male 
 
51 
 
 
100 
 
14 
 
 
100 
 
33 
 
 
100 
 
310
7 
 
97.79
2.21 
 
13  
 
 
100 
Degree 
Certificate 
Associate 
B.S. 
Master’s 
 
 
20 
23 
8 
 
 
39.224
5.1015.
69 
 
 
2 
7 
5 
 
 
14.29
50.00
35.71 
 
 
9 
20 
4 
 
 
27.27
60.61
12.12 
 
3 
138 
154 
22 
 
0.95 
43.53
48.58
6.94 
 
 
5  
5  
3  
 
 
38.46
38.46
23.08 
Clinical Setting 
Private 
Public Health 
Specialty 
Practice 
Educational  
Research 
Facility 
Hospital 
Cancer Care 
Center 
 
41  
5  
3  
 
5  
1  
 
1  
1  
 
80.399.
80 
5.88 
 
9.80 
1.96 
 
1.96 
1.96 
 
4 
3 
 
 
7 
 
 
 
 
 
 
28.57
21.43 
 
 
50.00 
 
25 
3 
1 
 
6 
 
 
 
75.76
12.12 
3.03 
 
18.18 
 
283 
24 
15 
 
36 
1 
 
 
 
 
89.27
7.57 
5.05 
 
11.36 
0.32 
 
 
9  
3  
 
 
3  
 
 
 
 
69.23
23.08 
 
 
23.08 
Years in Practice 
0-3  
4-6 
7-10 
10-15 
>15  
 
14  
10  
4  
5  
18  
 
27.45 
19.61 
7.84 
9.80 
35.29 
 
3 
 
 
4 
7 
 
21.43 
 
 
28.57
50.00 
 
7 
5 
4 
4 
13 
 
21.21
15.15
12.12
12.12
39.39 
 
51 
35 
34 
49 
148 
 
16.09
11.04
10.73
15.46
46.69 
 
1  
 
2  
2  
8  
 
7.69 
 
15.38
15.38
61.54 
 
Statistical Analysis 
 Are dental hygienists knowledgeable of the risks of oral HPV?  The first 
research question sought to determine if dental hygienists are knowledgeable of the risks 
of contacting oral HPV.  The participating dental hygienists rated themselves on a five-
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point Likert knowledge scale (Table 2).  The dental hygienists also answered questions 
regarding oral HPV related to incidence, mode of transmission, populations at risk, and 
lesion location.  Dental hygienists felt knowledgeable at varying levels to discuss oral 
HPV and cancer with their patients (n=296, 69.98%).  Thirty percent of the surveyed 
dental hygienists (n=127) felt unknowledgeable or very unknowledgeable about oral 
HPV and cancer.   
Table 2  
Dental Hygienists’ Self Rating of Oral HPV Knowledge 
  Knowledgeable  Unknowledgeable 
  Very  Somewhat  Normal  Somewhat Very  
 N n % n % n %  n % n % 
State 
CN 
MI 
OK  
WI 
WA  
 
50 
14 
33 
13 
313 
 
5 
4 
3 
1 
29 
 
10.0 
28.57 
9.03 
7.69 
9.27 
 
23 
6 
12 
6 
118 
 
46.0 
42.86 
36.36
46.15
37.70 
 
8 
2 
6 
1 
72 
 
16.0 
14.29 
18.18 
7.69 
23.00 
  
14 
2 
10 
5 
75 
 
28.0 
14.29 
30.30 
38.46 
23.96 
 
 
 
2 
 
19 
 
 
 
6.06 
 
6.07 
Age 
(years) 
≤30   
31-40  
41-50  
≥51  
 
 
86 
111 
69 
157 
 
 
4 
14 
6 
18 
 
 
4.65 
12.61 
8.70 
11.46 
 
 
33 
40 
26 
66 
 
 
38.37 
36.04 
37.68 
42.04 
 
 
18 
26 
18 
27 
 
 
20.93 
23.42 
26.09 
17.20 
  
 
24 
27 
18 
37 
 
 
27.91 
24.32 
26.09 
23.57 
 
 
7 
4 
1 
9 
 
 
8.14 
3.60 
1.45 
5.73 
Education   
Degree 
Cert. 
AS  
BS 
MS 
 
 
3 
173 
206 
41 
 
 
 
8 
22 
12 
 
 
 
4.62 
10.68 
29.27 
 
 
1 
69 
78 
17 
 
 
33.33
39.88 
37.86 
41.46 
 
 
1 
45
35
8 
 
 
33.33 
26.01 
16.99 
19.51 
  
 
 
46
57
3 
 
 
 
26.59 
27.67 
7.32 
 
 
1 
5 
14
1 
 
 
33.33 
2.89 
6.80 
2.44 
Years in 
Practice 
0-3  
4-6  
7-10  
10-15  
≥15  
 
 
76 
50 
43 
63 
191 
 
 
5 
3 
4 
10 
20 
 
 
6.58 
6.0 
9.30 
15.87 
10.47 
 
 
29 
18 
15 
26 
77 
 
 
38.16
36.0 
34.88 
41.27 
40.31 
 
 
19 
10 
9 
11 
40 
 
 
25.0 
20.0 
20.93 
17.46 
20.94 
  
 
19 
15 
14 
14 
44 
 
 
25.0 
30.0 
32.56 
22.22 
23.04 
 
 
4 
4 
1 
2 
10 
 
 
5.26 
8.0 
2.33 
3.17 
5.24 
  
Table 3 represents the analysis of dental hygienists from rural versus urban areas 
and their self-perceived knowledge levels.  When comparing feelings of knowledge using 
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Goodness-of-Fit Test, a relationship was present comparing respondents from rural areas 
versus urban areas and feeling that they have normal knowledge of oral HPV (p=0.0436).  
Of the respondents from urban areas (n=50), 18% felt they had a normal knowledge of 
oral HPV, which was less than expected.  Comparatively, 28% the respondents from rural 
areas (n=39) felt they had a normal knowledge of oral HPV, which was more than 
expected statistically.  
Table 3 
Dental Hygienists’ Self-Perceived Knowledge Level Based on Population Density 
 Urban  Rural  
 fo fe  fo fe p
**
 
Very Knowledgeable 
Somewhat Knowledgeable 
Knowledgeable 
Somewhat 
Unknowledgeable 
Very Unknowledgeable 
30 
116 
50 
 
69 
16 
28 
110 
59 
 
70 
14 
 12 
49 
39 
 
37 
5 
14 
55 
30 
 
36 
7 
0.5127 
0.3218 
0.0436 
 
0.8375 
0.3545 
Total 281   142   
Note: fo=observed frequency; fe=expected frequency.  fe may not equal n due to rounding 
**Confidence Internal, α=95%.  *p<0.05. 
 
 When comparing all educational categories, considerations were made because 
frequencies within the Certificate and Master’s group had some knowledge level 
frequencies of less than 5 or 0.  Therefore, for improved statistical significance, 
groupings were created with various degree levels (see Table 4).  Education level was 
found to have significant difference amongst respondents’ self-perceived knowledge 
level when comparing dental hygienists with Certificate and Associate degrees against 
dental hygienists with Bachelor’s and Master’s degrees for all levels of knowledge 
(p=0.0068).  Those dental hygienists with higher level of educational degree were more 
likely to identify themselves as being ‘very knowledgeable’.  When comparing only 
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dental hygienists with Associate degrees versus those with Bachelor’s degree against all 
levels of knowledge, statistical significance was found (p=0.0268).  From earlier, Table 2 
depicts how dental hygienists from each educational group rated themselves on the Likert 
scale for knowledge. 
Table 4 
Self-Perceived Knowledge Level Comparing Education Levels 
 All Levels of 
Knowledge 
 Knowledgeable versus 
Unknowledgeable 
 p-value  p-value 
All Levels of Education   0.0001**      0.0159** 
Associates versus 
Bachelor’s 
0.0268*  0.3007 
Certificate & Associate 
versus Bachelor’s & 
Master’s 
0.0068*  0.3007 
Associate & Bachelor’s 
versus Master’s 
  0.0001**      0.0029** 
Note: p-values based from x
2 
contingency analysis comparing self-perceived knowledge 
level.  Knowledgeable grouped very knowledgeable, somewhat knowledgeable, and 
knowledgeable.  Unknowledgeable grouped somewhat unknowledgeable and very 
unknowledgeable.  Confidence Interval, α=0.05, *p<0.05.  **Calculations included some 
categories with less than 5 frequencies.  Caution should be used when considering these 
statistics. 
 
 
 
 Statistical analysis did not determine significance for the questions pertaining to 
dental hygienists ability to identify facts about oral HPV including incidence, mode of 
transmission, populations at risk, and tumor location.  Based on this survey, the dental 
hygienists correctly identified that the incidence of oral HPV in OPC is rising (96.15%, 
n=400) (see Appendix C Table C1).  Most of the dental hygienists selected oral sexual 
contact as the mode of transmission for oral HPV (n=323, 78.21%).   
 Table 5 depicts responses to the populations at risk and tumor location questions 
that allowed for multiple answers.  Seventy-seven percent (n=319) of the respondents 
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correctly identified age 22-55 as a population at risk.  Sixty-two percent (n=254) of the 
dental hygienists identified women as the highest gender at risk for oral cancer caused by 
HPV.  Forty-eight percent (n=201) identified men as the gender most at risk for oral 
HPV.  Thirty-two percent of respondents (n=131) identified Caucasians as being a 
population at risk for oral HPV.  Fifty-seven percent of dental hygienist (n=222) 
identified the palatal tonsils as the most common location for oral HPV while 37% 
(n=142) identified the lingual tonsils.  The question that requested selection of the most 
likely tumor location had the lowest response with 388 replies of the 428 dental hygienist 
sample.  
Table 5 
Dental Hygienists’ Knowledge of Populations at Risk and Common Tumor Location for 
Oral HPV 
 
 
Response Rates 
N % 
Populations at Risk 
Men 
Women 
Age 20-55 
Age 55+ 
Heterosexuals 
Homosexuals 
Caucasian  
African American 
Mexican and Native American  
Common Tumor Location 
Hard palate 
Dorsal surface of the tongue 
Lateral border of the tongue 
Vestibules 
Lingual tonsils 
Floor of the mouth 
Palatal tonsils 
 
201 
254 
319 
63 
180 
140 
131 
91 
67 
 
121 
105 
155 
84 
142 
108 
222 
 
48.79 
61.65 
77.43 
15.29 
43.69 
33.98 
31.80 
22.09 
16.26 
 
31.27 
27.13 
40.05 
21.71 
36.69 
27.91 
57.36 
Note: Respondents were able to select more than one population.  Therefore, the results 
were reviewed for common trends. 
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Are dental hygienists in the United States educating their patients about the risk 
of OPC caused by HPV?  The second research question posed if dental hygienists in the 
United States are educating patients about the risk of OPC caused by HPV.  Results show 
dental hygienists are educating patients on the risks associated with oral HPV some of the 
time (n=177, 42.04%) or not at all (n=225, 53.44%).  The dental hygienists who educate 
patients about the risk of oral HPV ‘some of the time’ do so if the patient has an area of 
concern (n=94, 64.38%), the clinician finds a suspicious lesion (n=101, 69.18%), or the 
patient has a history of HPV (n=113, 77.40%).   
The results suggest educational degree has an impact on the likelihood of the 
dental hygienist to include this information when providing patient education.  When 
analyzing education level excluding certificates, statistical significance was found for 
frequency of providing oral HPV education to ‘every patient’ (p=0.0099; see Table 6).  
Those dental hygienists with Master’s degrees were discussing oral HPV with every 
patient more than statistically expected.  Comparing all levels except certificates, 
contingency analysis found a relationship to exist for dental hygienists within these 
groups educating patients ‘always’ and ‘some of the time’ versus never (p=0.0017; see 
Table 7).  There was also significance found for this same group comparison when 
evaluating ‘always’ versus ‘never’ (p=0.0001) as well as all frequency options of 
‘always’, ‘some of the time’, and ‘never’ (p=0.0005; see Table 7).  Most dental 
hygienists with Master’s degrees included oral HPV education ‘all of the time’ (n=6, 
15%) and ‘some of the time’ (n=23, 58%) in patient education.  For dental hygienists 
with Bachelor’s degrees, patients received oral HPV education all of the time by 4% 
(n=8) of the dental hygienists and some of the time by 38% (n=78) of the dental 
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hygienists.  Dental hygienists with Associate degrees included oral HPV education for all 
patients 3% of the time (n=5) and for some patients 43% of the time (n=75). Using 
Contingency Analysis comparing those dental hygienists with Certificates, Associated 
degrees, and Bachelor’s degrees to Master’s degrees, a significant relationship was found 
comparing all patterns of including oral HPV information in patient education (p=0.0001; 
see Table 7).   
Table 6 
Dental Hygienists Discussing Oral HPV with Patients 
 Every Patient Some Patients Never 
 fo fe p-value fo fe p-value fo fe p-value 
State 
Connecticut  
Mississippi  
Oklahoma  
Washington 
Wisconsin  
 
2 
2 
1 
13 
0 
 
2 
1 
1 
13 
1 
0.7358 
 
 
21 
2 
14 
131 
6 
 
21 
6 
13 
129 
5 
0.5621  
27 
7 
17 
167 
7 
 
27 
7 
17 
167 
7 
1.0000 
Age (in years) 
≤30 
31-40 
41-50  
≥51  
 
2 
3 
5 
9 
 
3 
5 
3 
7 
0.2952** 
 
 
36 
42 
28 
71 
 
36 
46 
29 
66 
0.8587  
 48 
64 
36 
77 
 
46 
58 
37 
84 
0.7249 
 
Education 
Degree 
Certificate  
Associate 
Bachelor’s 
Master’s 
 
 
0 
5 
8 
6 
 
 
0 
8 
9 
2 
1.000** 
0.0099
+
* 
 
 
 
 
1 
75 
78 
23 
 
 
1 
72 
87 
17 
    
0.3656** 
0.2046
+ 
 
 
2 
92 
120 
11 
 
 
2 
92 
110 
21 
0.1288** 
0.0587
+ 
 
 
Years in Practice 
0-3  
4-6 
7-10 
10-15 
≥15  
 
1 
1 
1 
4 
12 
 
3 
2 
2 
3 
9 
0.4530 
 
 
35 
19 
17 
21 
85 
 
32 
21 
18 
27 
80 
0.7722  
40 
30 
24 
38 
93 
 
41 
27 
22 
34 
102 
0.8009 
 
 
Note: P-values based from x
2 
independence analysis comparing frequency of including 
oral HPV with patients with Goodness-of-Fit.  Confidence Interval, α=0.05, *p<0.05.  
**Frequencies included some with less than 5.  Caution should be used when considering 
these statistics. 
 +
Excludes certification results. 
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Table 7 
Dental Hygienists’ Education Level in Relationship to Oral HPV Education 
 Frequency of Inclusion During Patient Education 
 
All Frequencies 
Always/Some 
of the Time 
versus Never 
Always versus 
Never 
 p-value p-value p-value 
All Levels of Education   0.0024** 0.0048** 0.0002** 
All Levels except Certificate 0.0005*      0.0017*       0.0001* 
Associates versus Bachelor’s        0.4960      0.3527       0.7273 
Certificate & Associate 
versus Bachelor’s & Master’s 
       0.3752      0.9253       0.1875 
Certificate, Associate & 
Bachelor’s versus Master’s 
0.0001*      0.0005*     <0.0001* 
Note: P-values based from x
2 
Contingency Analysis comparing pattern of including oral 
HPV information in patient education.  Confidence Interval, α=0.05,*p<0.05.  
**Calculations included some categories with less than 5 frequencies.  Caution should be 
used when considering these statistics. 
 
 
 
The survey found dental hygienists are mostly not discussing the possible modes 
of transmission with their patients (n=246, 61.81%).  Significant differences were not 
found for location, population density, or gender.  They do so if the patient has an area of 
concern (n=73, 63.48%), the clinician finds a suspicious lesion (n=85, 73.91%), or the 
patient has a history of HPV (n=85, 74.78%).  
Age appeared to play a role in never discussing the possible modes of oral HPV 
transmission versus always discussing it.  A relationship was found from contingency 
analysis in the decision to ‘always’ or ‘never’ discuss oral HPV transmission increases 
when comparing those younger than 50 to those 50 years of age or older (p=0.0164).  
Most dental hygienists over 50 years of age do not discuss oral HPV transmission during 
patient education (n=88, 59.46%).  There was a significant difference between dental 
hygienists who have practiced for more than 15 years and the unlikeliness to include 
mode of oral HPV transmission in patient education when comparing each option of 
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‘always’, ‘some of the time’, and ‘never’ (p=0.0100).  A similar finding was discovered 
comparing this same group but considering ever discussing this as ‘always’ and ‘some of 
the time’ versus ‘never’ (p=0.0162).  Table 8 depicts these relationships. 
Table 8 
Age and Frequency of Including Oral HPV Mode of Transmission in Patient Education 
 Frequency of Inclusion During Patient Education 
 
 
 All Frequencies 
Always/Some 
of the Time 
versus Never 
Always versus 
Never 
 p-value p-value  p-value 
Age Comparison 
All Ages 
 
  0.2487** 
 
 0.4880 
   
 0.0940** 
<30<   0.6382**  0.6676       0.5323 
<40<   0.1056**  0.3115   0.0350** 
<50<        0.0545  0.4579       0.0164 
Years if Practice Comparison 
All years in practice 
 
  0.2279** 
 
 0.3803 
   
 0.5970** 
<3<   0.1970**  0.3656  0.0764** 
<6<   0.0687** 0.2055   0.1882** 
<10<        0.0815 0.5965  0.1158** 
<15< 0.0100* 0.5184       0.0162* 
Note: P-values based from x
2 
contingency analysis comparing pattern of including oral 
HPV information in patient education.  Confidence Interval, α=0.05, *p<0.05.  
**Calculations included some categories with less than 5 frequencies.  Caution should be 
used when considering these statistics. 
 
 
 
When analyzing if a relationship exists for educational level and including oral 
HPV information in patient education ‘always’ and ‘some of the time’ versus ‘never’ 
doing so, significance was found between those dental hygienists with Associate degrees 
and Bachelor’s degrees versus Master’s degrees (p=0.0080).  Contingency analysis was 
run for all educational level groupings with other significance found, but due to low 
frequencies of less than 5, the statistics should be considered cautiously when comparing 
them to all dental hygienists.  These are depicted in Table 9. 
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Table 9 
Education Level and Frequency of Including Oral HPV Transmission in Patient 
Education 
 Frequency of Inclusion During Patient Education 
 
All Frequencies 
Always/Some 
of the Time 
versus Never 
Always versus 
Never 
 p-value p-value  p-value 
All Levels of Education  0.0295** 0.0702** 0.0037** 
All Levels except Certificate  0.0079**      0.7214 0.0013** 
Certificate & Associate 
versus Bachelor’s  
      0.2461      0.5468       0.0941 
Associates versus Bachelor’s       0.5913      0.8815       0.3661 
Associate & Bachelor’s 
versus Master’s 
 0.0014**      0.0080*  0.0003** 
Note: P-values based from x
2 
contingency analysis comparing pattern of including oral 
HPV information in patient education.  Confidence Interval, α=0.05, *p<0.05.  
**Calculations included some categories with less than 5 frequencies.  Caution should be 
used when considering these statistics. 
 
 
 
 Are dental hygienists screening patients with intraoral screenings and risk 
assessment tools to determine their risk for oral HPV?  The third research question 
attempted to find if dental hygienists are screening patients with intraoral screenings and 
risk assessment tools to determine if patients are at risk for oral HPV.  Three hundred 
forty-one dental hygienists reported performing intraoral screenings on every patient 
(81.61%).  Only two of the 423 dental hygienists that responded to this question reported 
not completing intraoral screenings (0.47%).  One of these two worked in pediatrics 
while the other did not provide direct patient care.  For those dental hygienists reporting 
‘some of the time’ completing the intraoral screenings, the reported reasons were if the 
patient has a concern (n=46, 79.31%) or the clinician observes a suspicious lesion (n=42, 
72.41%).  Significance was found between levels of education excluding the certificates 
and performing risk assessments for every patient (p=0.0344).  Educational level 
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significance is discussed further in this section.  No other significant differences were 
discovered in the statistical analysis.  
Table 10 
Practice Patterns of Dental Hygienists Who Perform Intraoral Screening and Risk 
Assessments for Every Patient 
 
  Perform Intraoral Screening 
on Every Patient 
 Complete Oral Cancer Risk 
Assessment on Every Patient 
  fo fe p-value  fo fe p-value 
State 
Connecticut  
Mississippi  
Oklahoma  
Wisconsin  
Washington 
 
46  
12 
26 
13  
244 
 
40 
11 
27 
252 
10 
0.8006 
 
  
31 
9 
16 
148 
8 
 
25 
7 
16 
157 
7 
0.6144 
 
Age (in years) 
30 or < 
31-40 
41-50 
>51  
 
 66 
84 
57 
134 
 
70 
89 
56 
127 
0.7927 
 
  
 38 
43 
41 
90 
 
43 
55 
35 
79 
0.1239 
 
Education Degree 
 
Certificate  
Associate 
Bachelor’s 
Master’s 
 
  
2 
137 
165 
37 
 
 
3 
138 
168 
33 
0.9088** 
0.7612
+ 
 
  
  
1 
77 
102 
32 
 
 
1 
86 
104 
21 
  0.0806** 
  0.0344
+
* 
 
Years in Practice 
0-3  
4-6 
7-10 
10-15 
≥15  
 
 59 
43 
28 
50 
161 
 
61 
40 
35 
52 
153 
0.7016 
 
  
27 
27 
20 
31 
107  
 
38 
25 
22 
31 
96 
0.3099 
 
Note: P-values based from x
2 
independence analysis of clinicians complete intraoral 
screenings and risk assessments for every patient with Goodness-of-Fit.  Confidence 
Interval, α=0.05, *p<0.05.  **Frequencies included some with less than 5.  Caution 
should be used when considering these statistics. 
 +
Excludes certification results. 
 
 Additionally, the third research question sought to discover the questions included 
in oral cancer risk assessments.  Fifty percent of dental hygienists (n=212) surveyed 
complete risk assessments on every dental hygiene patient.  Nineteen percent (n=82) do 
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not provide risk assessments for dental hygiene patients.  Reasons for occasional 
completing risk assessments were: suspicious tissue (n=68, 95.77%), patient area of 
concern (n=54, 76.06%), tobacco history (n=56, 78.87%), alcohol abuse history (n=39, 
54.93%), and HPV history (n=28, 39.44%).  Table 11 details the results of frequency 
inclusion of possible risk factors for oral HPV on oral cancer risk assessments.  Fifty-
eight respondents (N=176) reported including questions pertaining to previous HPV 
presence.  Thirty-three respondents (N=176) included questions related to sexual history 
in their risk assessments for oral cancer.  
Table 11 
Risk Factors Included in Risk Assessments for Oral Cancers 
 Frequency of Questions including is Risk 
Assessments  
 n % 
Tobacco History  173 98.30 
Tobacco Use Frequency 157 89.20 
Alcohol History 118 76.05 
Alcohol Use Frequency 108 61.36 
Marijuana History 47 26.70 
Marijuana Use Frequency 44 25.00 
Sexual History 33 18.75 
HPV History 58 32.95 
 
 Educational levels, excluding certificates, have a dependent relationship with 
dental hygienists’ inclusion of risk assessments for every patient as mentioned earlier 
(p=0.0344, see Table 10).  Dental hygienists with Associate degrees (n=77) complete risk 
assessments for oral cancer on every patient 45% of time.  Dental hygienists with 
Bachelor’s degrees (n=102) complete oral cancer risk assessment 49% of the time.  
Those dental hygienists with Master’s degrees (n=32) report completing oral cancer risk 
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assessments for patients 76% of the time.  Contingency analysis showed possible 
relationships between education level and risk assessments, but due to small sample sizes 
of dental hygienists with Certificates and Master’s degrees; these results need to be 
considered cautiously (Table 12).   
Table 12 
Pattern of Dental Hygienists Completing Oral Cancer Risk Assessments for Patients 
 Frequency of Inclusion During Patient Education 
 
All Frequencies 
Always/Some/Rarely 
versus Never 
 p-value p-value 
All Levels of Education   0.0121**     0.1175** 
Associates versus Bachelor’s                0.3654 0.3521 
Certificate & Associate 
versus Bachelor’s & Master’s 
  0.1460** 0.6944 
Associate & Bachelor’s 
versus Master’s 
  0.0039**     0.0355** 
Note: P-values based from x
2 
contingency analysis comparing pattern of including risk 
assessment for patient care.  Confidence Interval, α=0.05, *p<0.05.  **Calculations 
included some categories with less than 5 frequencies.  Caution should be used when 
considering these statistics. 
 
 
 
 Age for all ranges shows a relationship with the frequency of including risk 
assessments for patients (p=0.0333).  Specifically above or below 40 years of age, shows 
a relationship with the likelihood to include risk assessments for patients (p=0.0042).  
Although the frequencies were less than 5 and should be considered cautiously, it is 
important to note that years in practice is linked with the likelihood to include or not 
include risk assessments for dental hygiene patients (p=0.0072).  Dental hygienists who 
have practiced less than 3 years showed a relationship with completing risk assessments 
(p=0.0016).  A relationship existed between practicing dental hygiene less than 10 years 
versus more than 10 years and including risk assessments (p=0.0106).  Table 13 
represents inclusion of oral cancer risk assessments by dental hygienists based on age and 
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years in practice.  Differences were noted in gender but the male sample was too small 
for statistical certainty.  
Table 13 
Dental Hygienists’ Age and Years in Practice In Relation to Risk Assessment Completion 
 Frequency of Risk Assessment for Patients 
 All frequencies Ever versus Never 
 p-value p-value 
Age Comparison 
All Ages 
<30< 
<40< 
<50< 
 
              0.0333* 
              0.1180 
              0.0042* 
              0.0636 
 
0.3089 
0.2487 
0.6236 
0.8957 
Years in Practice 
Comparison 
All years of practice 
<3< 
<6< 
<10< 
<15< 
 
 
0.0072** 
              0.0016* 
              0.1496 
              0.0106* 
              0.0708 
 
 
    0.2154** 
0.3929 
0.9334 
0.2284 
0.8135 
Note: P-values based from x
2 
contingency analysis comparing pattern of including oral 
cancer risk assessment in patient care.  Confidence Interval, α=0.05, *p<0.05.  
**Calculations included some categories with less than 5 frequencies.  Caution should be 
used when considering these statistics. 
 
 
 
Why are dental hygienists deciding to discuss or not discuss HPV OSSC?  The 
fourth research question sought to uncover why dental hygienists are choosing to discuss 
or not discuss HPV OSCC.  Those dental hygienists surveyed reported feeling 
comfortable discussing oral cancer caused by HPV with patients (n=257, 61.2%).  Table 
14 identifies dental hygienists’ reported comfort level by state as well as by age, level of 
education, and years in practice (see Table 14).  
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Table 14 
Dental Hygienists’ Feelings of Comfort Discussing Oral HPV Risks 
  Comfortable  Uncomfortable 
  Very  Somewhat Normal  Somewhat Very 
 N n % n % n %  n % n % 
State 
Connecticut  
Mississippi 
Oklahoma  
Wisconsin 
Washington  
 
50 
14 
33 
13 
313 
 
9 
2 
2 
1 
30 
 
17.65 
14.29 
6.06 
7.69 
9.71 
 
15 
7 
7 
4 
68 
 
29.41 
50.0 
21.21 
30.77 
22.01 
 
10 
2 
13 
2 
85 
 
19.61 
14.29 
39.39 
15.38 
27.51 
  
17 
2 
10 
5 
108 
 
33.33 
14.29 
30.30 
38.46 
34.95 
 
 
1 
1 
1 
18 
 
 
7.14 
3.03 
7.69 
5.83 
Age  
(in years)  
30 or less  
31-40  
41-50  
>51   
 
 
86 
109 
69 
156 
 
 
7 
14
5 
18 
 
 
8.14 
12.8 
7.25 
11.54 
 
 
16 
22 
26 
37 
 
 
18.60 
20.18 
37.68 
23.72 
 
 
32 
24 
18 
38 
 
 
37.21 
22.02 
26.09 
24.36 
  
 
28 
44 
14 
56 
 
 
32.56 
40.37 
20.29 
35.90 
 
 
3 
5 
6 
7 
 
 
3.49 
4.59 
8.70 
4.49 
Education 
Degree 
Certificate  
Associate  
Bachelor’s  
Master’s  
 
 
3 
170 
206 
41 
 
 
 
15 
20  
9 
 
 
 
8.82 
9.71 
21.95 
 
 
1 
33 
50 
17 
 
 
33.33 
19.41 
24.27 
41.46 
 
 
 
51
50
11 
 
 
 
30.0 
24.2 
26.83 
  
 
2 
60 
77 
3 
 
 
66.67 
35.29 
37.38 
7.32 
 
 
 
11 
9 
1 
 
 
 
6.47 
4.37 
2.44 
Years in 
Practice 
0-3  
4-6  
7-10 
10-15  
>15  
 
 
76 
50 
41 
64 
189 
 
 
6 
6 
5 
6 
21 
 
 
7.89 
12.0 
12.2 
9.38 
11.11 
 
 
17 
9 
8 
16
51 
 
 
22.37 
18.0 
19.51 
25.0 
26.98 
 
 
26
10
14
13
49 
 
 
34.21 
20.0 
34.15 
20.31 
25.93 
  
 
26 
22 
12 
23 
59 
 
 
34.21 
44.0 
29.27 
35.94 
31.22 
 
 
1 
3 
2 
6 
9 
 
 
1.32 
6.0 
4.88 
9.38 
4.76 
 
The data analysis found significant difference in dental hygienists discussing the 
risks of oral HPV depending on educational level when excluding the certificates 
responses due to low frequency (Table 15).  Excluding Certificate level dental hygienists’ 
responses, ‘very comfortable’ responses showed a relationship with educational levels 
(p=0.0312) as did ‘somewhat comfortable’ (p=0.0391).  Those dental hygienists with 
Master’s degrees rated themselves as ‘very comfortable’ almost twice more than 
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expected statistically.  Those dental hygienists with Bachelor’s and Master’s degrees felt 
‘somewhat comfort’ more frequently that statistically expected.  Contingency analysis 
found relationships when comparing the different groups of educational levels with their 
feelings of comfort discussing oral HPV.  However, the significant results included 
frequencies from the group Master’s degrees that had less than 5 frequencies due to small 
sample size.  Appendix C Table C2 provides the information regarding the dental 
hygienists’ comforts levels discussing oral HPV risks with patients based on the 
clinician’s age.  
Table 15 
Dental Hygienists’ Feelings of Comfort Discussing Oral HPV Risks 
 Comfortable Uncomfortable 
 Very Somewhat Normal Somewhat Very 
 fo fe fo fe fo fe fo fe fo fe 
Education 
Degree 
Certificate  
Associate 
Bachelor’s 
Master’s 
 
 
0 
15 
20 
9 
 
 
0 
18 
22 
4 
 
 
1 
33 
50 
17 
 
 
1 
31 
50 
10 
 
 
0 
51 
50 
11 
 
 
1 
45 
55 
11 
 
 
2 
60 
77 
3 
 
 
1 
58 
77 
3 
 
 
0 
11 
9 
1 
 
 
0 
9 
10 
2 
p-value for all 1.000** 0.0904** 0.5213** 0.0148**  1.000** 
p-value 
excluding 
Certificates 
0.0312**
+ 
0.0391
+
*  0.6071
+ 
 0.5932 
Note: p-values based from x
2 
independence analysis comparing clinicians comfort 
discussing oral HPV risks with Goodness-of-Fit.  Confidence Interval, α=0.05.*p<0.05.  
**Frequencies included some with less than 5.  Caution should be used when considering 
these statistics. 
 +
Excludes certification results. 
   
 Why are dental hygienists opting to discuss or not discuss HPV vaccination 
availability with their patients?  The survey lastly intended to determine if dental 
hygienists are opting to discuss or not discuss HPV vaccine availability with patients.  
Dental hygienists are likely to consider recommending HPV vaccination consideration to 
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patients (61.19%, n=257).  Table 16 shows the reported comfort levels of dental 
hygienists’ per location, age, education level, and years of experience.     
Table 16 
HPV Vaccination Recommendation to Consider Likelihood 
  Very likely 
Somewhat 
likely Likely Unlikely 
Very 
unlikely 
 N n % n % n % n % n % 
State 
Connecticut  
Mississippi  
Oklahoma  
Wisconsin  
Washington  
 
50 
14 
33 
13 
313 
 
9 
2 
2 
1 
30 
 
17.65 
14.29 
6.06 
7.69 
9.71 
 
15 
7 
7 
4 
68 
 
29.41 
50.0 
21.21 
30.77 
22.01 
 
10 
2 
13 
2 
85 
 
19.61 
14.29 
39.39 
15.38 
27.51 
 
17 
2 
10 
5 
108 
 
33.33 
14.29 
30.30 
38.46 
34.95 
 
 
1 
1 
1 
18 
 
 
7.14 
3.03 
7.69 
5.83 
Age 
 (in years) 
≤30  
31-40  
41-50  
≥51  
 
 
84 
109 
69 
158 
 
 
15 
24 
5 
38 
 
 
17.86 
22.02 
7.25 
24.05 
 
 
151
826
40 
 
 
17.86 
16.51 
37.68 
24.32 
 
 
182
1 
18 
25 
 
 
21.43 
19.27 
26.09 
15.82 
 
 
23 
37 
14 
39 
 
 
27.38 
33.94 
20.29 
24.68 
 
 
13 
9 
6 
16 
 
 
15.48 
8.26 
8.70 
10.13 
Education 
Degree 
Certificate  
Associate  
Bachelor’s  
Master’s  
 
 
2 
171 
205 
42 
 
 
 
33
42
20  
 
 
 
19.30 
20.49 
47.62 
 
 
1 
28 
44 
10  
 
 
50.0 
16.37 
21.46 
23.81 
 
 
 
373
66  
 
 
 
21.64 
17.56 
14.29 
 
 
1 
47 
59 
4 
 
 
50.0 
27.49 
28.78 
9.52 
 
 
 
26 
24 
2 
 
 
 
15.20 
11.71 
4.76 
Years in 
Practice 
0-3  
4-6  
7-10  
10-15  
≥15  
 
 
74 
50 
42 
63 
191 
 
 
15
10 
9 
13 
48  
 
 
20.27 
20.0 
21.43 
20.63 
25.13 
 
 
12 
6 
7 
13 
45  
 
 
16.22 
12.0 
16.67 
20.63 
23.56 
 
 
20 
10 
5 
9 
35  
 
 
27.03 
20.0 
11.90 
14.29 
18.32 
 
 
16 
20 
15 
17 
43 
 
 
21.62 
40.0 
35.71 
26.98 
22.51 
 
 
11  
4 
6  
11 
20 
 
 
14.86 
8.0 
14.29 
17.46 
10.47 
 
 Educational level also has relationship to dental hygienists feeling very likely to 
discuss HPV vaccine options with patients (p=0.0036 excluding certificates; Table 17).  
A relationship was found comparing dental hygienists with Master’s degrees to others’ 
feeling likely or unlikely to discuss vaccine availability with patients (0.0006).   Those 
with Master’s degrees felt more likely of various levels to discuss HPV vaccines and less 
unlikely than expect.  Similar results were found comparing Bachelor’s and Master’s 
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degree; although the Bachelor’s degrees had very differences of observed and expected 
frequencies for each category (p=0.0013).  Table 18 illustrates these associations.   
Table 17 
Dental Hygienists’ Likeliness to Discuss HPV Vaccine Availability by Educational Level 
 
 Comfortable Uncomfortable 
 Very Somewhat Normal Somewhat Very 
 fo fe fo fe fo fe fo fe fo fe 
Education 
Degree 
Certificate  
Associate 
Bachelor’s 
Master’s 
 
 
0 
15 
20 
9 
 
 
0 
18 
22 
4 
 
 
1 
33 
50 
17 
 
 
1 
31 
50 
10 
 
 
0 
51 
50 
11 
 
 
1 
45 
55 
11 
 
 
2 
60 
77 
3 
 
 
1 
58 
77 
3 
 
 
0 
11 
9 
1 
 
 
0 
9 
10 
2 
p-value for all 1.000** 0.0904** 0.5213** 0.0148** 1.000** 
p-value 
excluding 
Certificates 
0.0312**
+ 
0.0391
+
* 0.6071
+ 
 0.5932 
Years in 
Practice 
0-3 
4-6 
7-10 
10-15 
>15 
 
 
15 
10 
9 
13 
48 
 
 
17 
11 
10 
14 
43 
 
 
12 
6 
7 
13 
45 
 
 
15 
10 
8 
12 
38 
 
 
20 
19 
5 
9 
35 
 
 
14 
10 
8 
12 
36 
 
 
116 
20 
15 
17 
43 
 
 
20 
13 
11 
17 
51 
 
 
11 
4 
6 
11 
20 
 
 
9 
6 
5 
8 
24 
p-value 0.8976 0.4484 0.3326 0.1357 0.5408 
Note: P-values based from x
2 
independence analysis comparing likeliness to discuss HPV 
vaccine availability with Goodness-of-Fit.  Confidence Interval, α=0.05. *p<0.05.  
**Frequencies included some with less than 5.  Caution should be used when considering 
these statistics. 
 +
Excludes certification results. 
 
When comparing average feelings of comfort discussing HPV vaccination with 
patients, a relationship was identified with years in practice for those dental hygienists 
who have practiced more than 15 years (p=0.0253).  Dental hygienists who have 
practiced for more than 15 years felt ‘somewhat likely’ discussing HPV vaccination more 
frequently than expected and ‘somewhat unlikely’ less frequently than expected (Table 
18).   
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Table 18 
Dental Hygienists’ Likeliness to Discussing HPV Vaccine Availability  
 Likeliness to discuss HPV Vaccine 
 All Frequencies Likely versus Unlikely 
 p-value p-value 
Degree Level Comparison   
All Levels of Education     0.0092**     0.0071** 
Associates versus Bachelor’s 0.5515 0.6660 
Certificate & Associate 
versus Bachelor’s & Master’s 
 0.2090  0.1629 
Associate & Bachelor’s 
versus Master’s 
     0.0003**   0.0006* 
Bachelor’s versus Master’s      0.0018**   0.0013* 
 
Years if Practice Comparison 
  
All Years in Practice 
<3< 
<6< 
<10< 
<15< 
 0.2767  
 0.2627 
 0.1922 
 0.1771 
 0.1560 
0.1019  
0.6514 
0.5278 
0.1207 
               0.0253* 
Note: p-values based from x
2 
contingency analysis comparing likeliness discussing HPV 
vaccine availability with patients based on degree level and years in practice.  Confidence 
Interval, α=0.05. *p<0.05.  **Calculations included some categories with less than 5 
frequencies.  Caution should be used when considering these statistics. 
 
 
 
Trends found in open-ended questions.  The open-ended questions allowed the dental 
hygienists to elaborate on their responses to the questions.  The common themes that 
emerged from analysis of the responses to the open-ended question regarding comfort 
discussing oral HPV with dental hygiene patients were: 
1.  Not enough knowledge; 
2. Patients or clinicians are uncomfortable discussing sexual history and sexually 
transmitted diseases;  
3. Clinicians are concerned with invading patient privacy and causing 
embarrassment for clinician or patient; and 
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4. The age of the patient, specifically for patient privacy and inability to discuss 
topic with teenagers without parental consent. 
Two hundred sixty-three participants responded to the first open-ended questions 
inquiring to discover if dental hygienists are uncomfortable, what barriers are preventing 
them from discussing oral HPV with patients.  Trends found for barriers in dental 
hygienists’ comfort of educating patient about HPV include lack of knowledge, 
uncertainty of risk factors and modes of transmission, and fear of an invasion of patient 
privacy.  Some dental hygienists identified operatories are not private and some dentists 
would be uncomfortable with dental hygienists discussing HPV with patients.  Dental 
hygienists also identified their discomfort discussing sexually related topics with patients 
in the dental setting as well as fear of patients discomfort in discussing topics related to 
sex.  Some identified the cultural environment of their office and town/city in which they 
practice. 
 The second open-ended question sought to determine dental hygienists’ overall 
anticipation of patient receptiveness to oral HPV education.  Forty-two of the 258 
(16.28%) respondents felt patients would not be receptive to this information.  Sixteen 
(6.20%) were unsure of how patients would react.  Sixty-two (24.03%) felt patients 
would possibly be receptive but that all may not be.  One hundred thirty-two dental 
hygienists felt patients would be receptive to this information (51.16%).  A common 
trend for uncertainty pertaining to patient receptiveness to HPV education is related to the 
patient’s age.  Cultural differences seemed to also be a factor in if dental hygienists think 
the patients will be receptive to the education.   
 83 
DENTAL HYGIENISTS AND HUMAN PAPILLOMAVIRUSES     
 
 In the last open-ended question, dental hygienists identified they felt oral HPV 
education is an important role for dental hygienists.  Overall, the respondents felt dental 
hygienists hold a role in educating patients about the risk of oral HPV cancers (N=263, 
n=212, 80.61%).  The dental hygienists also identified the need for dentists, medical 
professionals (specifically women’s health professionals), and schools sexual education 
programs to provide oral HPV information to young adults.    
Summary 
As a whole, dental hygienists are aware of the incidence of oral HPV in 
oropharyngeal cancers rising (n=400, 96.15%).  They believe it is important for dental 
hygienists to provide oral HPV education to their patients and report feeling comfortable 
(n=257, 61.2%) and knowledgeable (n=296, 69.98%) to do so.  However, most state they 
feel they would be more comfortable if they were more knowledgeable.  Education level 
appears to have a relationship with self-perceived knowledge and comfort as well as 
frequency of intraoral screening, risk assessments, and patient education including oral 
HPV.       
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Discussion 
 
Summary of Major Findings 
This study found dental hygienists are aware of the rising incidence of oral HPV 
(n=400, 96.15%).  Dental hygienists feel various levels of knowledge about oral HPV 
and cancer with more feeling knowledgeable (n=296, 69.98%) than not.  However, lack 
of knowledge is the most common theme reported for barriers to providing this 
information to patients.  Dental hygienists are infrequently (n=177, 42%) or never 
(n=225, 53.44%) educating patients about the risk of oral HPV.  They are discussing the 
modes of oral HPV transmission even less.  A majority of dental hygienists are 
performing intraoral screenings (n= 341, 81.61%) and are completing oral cancer risk 
assessments (n=212, 50%) for patients.  Dental hygienists feel levels of comfort (n=257, 
61.2%) discussing oral HPV and cancer with their patients while 39% feel ‘somewhat 
uncomfortable’ (n= 142, 34%) or ‘very uncomfortable’ (n=.21, 5%)  Few dental 
hygienists are uncomfortable discussing oral HPV with patients; however, most state they 
feel uncomfortable discussing sexual transmitted infections with patients due to patient 
age, specifically, need for parental consent, lack of knowledge, and embarrassment 
discussing sexual topics for the patient or the clinician.  They are likely to discuss oral 
HPV vaccine availability with their patients.  
Discussion 
 Are dental hygienists knowledgeable of the risks of oral HPV?  Dental 
hygienists are knowledgeable about oral HPV regardless of state location, age, and years 
in practice.  This survey found dental hygienists are aware of the rising incidence of oral 
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HPV (n=400, 96.15%).  Most of the dental hygienists selected oral sexual contact as the 
mode of transmission for oral HPV.  Increased sexual history has shown in several results 
to also be a risk factor for oral HPV but respondents were only allowed to select one 
option (Applebaum et al., 2007; D'Souza et al., 2009; Gillison et al., 2004; Gillison et al., 
2008; Herrero et al., 2003; Schwartz et al., 1998; Smith et al., 1998; Smith et al., 2004).  
Very few identified kissing as a mode of transmission.  Some research has shown this to 
also be a transmission mode for the virus orally (D'Souza, Agrawai, Halpern, Bodison, & 
Gillison, 2009).   
The majority of dental hygienists were able to identify the age group (22 to 55 
years of age) as at risk but less than half could identify Caucasian males as at risk.  They 
were able to identify the palatal tonsils as common tumor locations, but only a third were 
able to identify the lingual tonsils.  It is worthwhile to note each question was optional to 
answer.  When asked to identify the common location for oral HPV tumors, respondents 
chose not to answer it which could indicate unawareness of the common oral HPV 
location. 
 Education level was found to contribute to a dental hygienist’s self-perception of 
knowledge because the higher the level of education reported by the dental hygienists the 
frequency of identifying themselves as ‘very knowledgeable’ increased.  Dental 
hygienists with Associate degrees identified themselves more than twice less than the 
expected rate (fo=8; fe=17).  Dental hygienists with Master’s degrees identified 
themselves as ‘very knowledge’ triple the expected response rate (fo=12 ; fe=4).  This 
could be due to the increasing length of study and clinical experience from associate level 
to graduate degree programs.  This additional time could be allowing for more study on 
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subjects related to oral pathology as well as additional clinical experience, which could 
increase exposure to oral cancer in general as well as confidence.  Some Bachelor’s 
degree dental hygienists are older because they may have graduated from a degree 
completion program; which means they could have more clinical experiences.  Those 
dental hygienists with Master’s degrees could also have higher perceived levels of 
knowledge due to the extension of study and experience in dental hygiene as well as an 
ongoing interest in continuing education courses.      
 Are dental hygienists in the United States educating their patients about the risk 
of OPC caused by HPV?  Not all dental hygiene patients are receiving education about 
oral HPV risks including the possible modes of transmission.  They do so if the patient 
has an area of concern, the clinician finds a suspicious lesion, or the patient has a history 
of HPV.  Educational level had significance in association with dental hygienists 
including oral HPV risks and modes of transmission in patient education.  Dental 
hygienists with Master’s degrees discuss the mode of transmission of oral HPV with 
‘every’ or ‘some of’ the patients more than ‘never’ doing so.  Associate and Bachelor’s 
degree dental hygienists discussed transmission of oral HPV with patients ‘always’ or 
‘some of the time’ less frequently and mostly did not discuss this topic.  This could be 
due to additional length of dental hygiene study allowing for more focus on patient 
education as well as the fact that some of these dental hygienists may have completed 
Bachelor’s degrees through degree completion programs.  
 Are dental hygienists screening patients with intraoral screenings and risk 
assessment tools to determine their risk for oral HPV?  Dental hygienists are 
performing intraoral screenings for their dental hygiene patients.  Earlier studies had 
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found dental hygienists perform the IO exams less frequently (Cotter et al., 2011).  For 
those dental hygienists reporting ‘some of the time’ completing the intraoral screenings, 
their reasons are if the patient has a concern or the clinician observes a suspicious lesion.   
 Half of the dental hygienists from the survey are using risk assessments to 
determine patients’ risks for oral cancer.  One-fifth of dental hygienists in this study do 
not ever include risk assessments in patient care.  Age of the dental hygienists contributes 
to the decision to include a risk assessment for patient care.  Dental hygienists older than 
40 years old perform risk assessments more than expected while those dental hygienists 
less than 40 years of age complete risk assessments for patients less than statistically 
expected.  Practicing less than 10 years also contributes to including a risk assessment for 
oral cancer.   
 For dental hygienists reporting ‘some of the time’, risk assessments were found to 
mostly be used for tobacco and alcohol histories, or if a suspicious lesion was located by 
the clinician or patient.  HPV history and sexual history appears less typically on risk 
assessments than tobacco and alcohol histories.  This could likely be due to oral HPV 
awareness only increasing in the last several years.  Additionally, there are still 
uncertainties regarding the role a history of HPV actually plays in chances of developing 
oral HPV.  The possibility of people with partners with a history of HPV could be more 
relevant to risk assessments.  Additionally, guidelines are not available at this time to 
provide clear direction of what sexual histories will increase the risk of contacting oral 
HPV let alone developing oral HPV cancers.   
 Why are dental hygienists deciding to discuss or not discuss HPV OSSC?  The 
survey found dental hygienists report being comfortable discussing the risk of oral cancer 
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caused by HPV.  However, an overwhelming response identified they do not feel they 
know enough about oral HPV and are therefore uncomfortable discussing this with 
patients.  They fear addressing sexual histories with patients could make the patient feel 
their privacy has been violated.  They are also concerned with the need for parental 
consent to address related topics with minor children.  Lastly, they do not feel every 
patient needs to be educated about the risk of oral HPV nor will be accepting of such 
information in the dental office.  However, the majority of dental hygienists do feel 
patients may be receptive to oral HPV education.  Only a small group felt patients would 
be unreceptive to oral HPV education, while the remaining respondents felt age was a 
determining factor in patient acceptance.  Dental hygienists felt they should be providing 
oral HPV education. 
 Why are dental hygienists opting to discuss or not discuss HPV vaccination 
availability with their patients?  There is currently no vaccination approved for oral HPV 
(CDC, 2011; CDC, 2012c).  However, most of the surveyed dental hygienists felt willing 
to discuss the option of HPV vaccination with their patients, particularly parents, if 
vaccines become approved to prevent oral HPV.   
Significance.  Dental hygienists have identified their role in helping dental 
patients learn about risk factors associated with contacting oral HPV.  They are aware of 
the rising incidence of oral HPV cancers.  The dental hygienist’s preventive role in oral 
health is an integral part of improving individuals’ understanding about the risk of HPV 
in the throat and may help patients, particularly young adults, reconsider the safety of 
sexual behaviors such as oral sex and open-mouthed kissing.  Providing these 
preventative facts for patients as well as screening for HPV OPC and risk factors could 
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be included in the current standard of dental hygiene care in preventing oral diseases 
(ADHA, 2008).  Identifying the need for more educational opportunities for dental 
hygienists pertaining to oral HPV provides direction for professional groups and 
professionals capable of delivering this information.  Areas that could be addressed 
related to oral HPV education include communication techniques to support dental 
hygienists and help patients feel comfortable discussing sexually related diseases when 
seeking dental care.   Additionally, dental professionals could begin to incorporate 
questions on the health history pertaining to sexual history to assist in identifying the 
need for oral HPV related risk discussions.    
Relationship to previous research.  Daley and colleagues’ Florida study (2011) 
lacks sample (N=38) size to represent the dentist and dental hygienists in the entire 
nation, yet study results identified the need for direction for dental health care providers 
to take on the role of educating patients about the risk of oral HPV.  This thesis continued 
from Daley et al. (2011) to target dental hygienists on a larger scale across the nation.  
Previously, there has been no research focused strictly on dental hygienists and their 
views about oral HPV patient education.  This study provided baseline information for 
dental hygienists determining the need for further research, education, and screening 
guidelines.   
Assumptions.  It was assumed dental hygienists would be somewhat 
knowledgeable about oral HPV and its associated risk factors due to media coverage and 
related articles in dental hygiene journals.  However, it was assumed dental hygienists 
would be avoiding discussing this topic during patient education due to feeling 
uncomfortable addressing oral HPV risks and transmission with the patient.  The results 
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self-perceived ratings of knowledge and comfort did not support this assumption.  
However, over half of the participants answered the open-ended question regarding 
discomfort and barriers preventing them from discussing oral HPV with patients.  Most 
of those that responded felt lack of knowledge was their main barrier in doing so.  
The high response rate was not anticipated due to the survey being sent during the 
summer months of July and August.  In deciding to use email to solicit participants, it 
was assumed the respondents would be from younger age groups with fewer years in 
practice due to more familiarity with technology for the email survey.  However, most of 
the respondents were over 50 years of age and had practiced more than 15 years.  It was 
expected most of the dental hygienists responding to the survey would have practiced less 
than 10 years.   Lastly, because there are more programs that offer Associate’s degrees in 
the US, it was expected most of the respondents would hold an Associate’s degree.  
However, most held a Bachelor’s degree which could be interrelated to the fact that the 
selected states offer Bachelor’s degree programs. 
Explanations of unanticipated findings.  Dental hygienists reported being more 
knowledgeable and comfortable than anticipated.  However, when reviewing the open-
ended question asking what barriers were present if respondents were uncomfortable 
discussing HPV with patients, the majority of those surveyed responded as being 
uncomfortable due to lack of knowledge.  The majority of respondents answered this 
question, which was optional and directed to those feeling uncomfortable about oral HPV 
education.  Therefore, the Likert scale questions may not have truly reflected the self-
perceived levels of knowledge and comfort as intended.  
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The statistical analysis found educational level to have a relationship with 
knowledge, screening frequencies, patient education, and comfort levels.  This statistical 
significance was an unexpected result.  This unanticipated finding could potentially 
identify a solution to improve dental hygienist knowledge, comfort, and frequency of 
screening and educating patients about the risk of oral HVP cancers.  
Implications.  This research can be used to identify the need for guidance about 
oral HPV from professional organizations for dental hygienists.  Professional 
organizations or groups of dental hygienists may recognize the opportunity to create 
patient education pamphlets or posters to help inform patients about the facts of oral 
HPV.  Increasing the opportunities for dental hygienists to attend continuing education 
courses, including online courses, should be considered from the results of this survey.  
Dental hygiene programs need to continue to include oral HPV education in oral 
pathology courses as well as in patient education assessments or competencies for dental 
hygiene students.  Additionally, dental hygiene program organizations should continue to 
encourage the movement for Associate degree programs to evolve into Bachelor’s of 
Science programs as well as encourage more degree completion programs.   
Most importantly, dental hygienists becoming more knowledgeable and 
comfortable to screen and educate patients of the risks of contacting oral HPV can 
encourage these patients to make positive, preventive decisions involving their oral and 
sexual health.  This could potentially cause a change in the increasing incidence of 
oropharyngeal cancers caused by HPV. 
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Limitations 
The participants were allowed skip questions so the responses varied per question.  
Additionally, some of the sample sizes were small for particular categories.  Therefore, 
some of the statistically significant results could be skewed due to these small sample 
responses.  If this study is repeated in the future, the survey settings should be changed so 
participants cannot bypass questions.  The will ensure consistent response rates for each 
question.  Additionally, the survey questions asking ‘some of the time’ should omit the 
reasons for ‘some of the time’ practice since they are addressed in the following question.   
Lastly, the survey did not collect data to determine if dental hygienists are completing 
intraoral exams and risk assessments in conjunction with one another.  This could help 
determine how well patients are being screened for risk of oral HPV by dental hygienists.  
The results of the survey were limited to only dental hygienists who were 
members of the selected states’ dental hygiene associations so there may have been 
sampling bias.  Perhaps the sheer motivation to be a member of state association, 
participants may be more likely to complete in the survey.  These states were selected 
conveniently due to availability to participate in the online survey.  These states do have 
Bachelor’s degree programs which could account for the higher percentage of dental 
hygienists with Bachelor’s degrees.  The randomly selected states were not equal in 
membership so therefore some states were over represented while others were less 
represented (Table 1).  Some of these small samples created low frequencies, which 
caused some of the results to be noted but unable to rely on as statistically significant.  
The sample size was significantly larger in Washington and response percentages 
may have been higher because EWU is in Washington State.  However, the PI felt it was 
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important to include the state where her education is taking place.  The respondents may 
have possibly graduated or been familiar with EWU which could increase likelihood to 
support and participate in this research.   
The survey was self-reported which can create sample bias.  Dental hygienists 
who did not complete the survey may not feel the topic has relevance in practice.  
Therefore, these individuals may not be completing intraoral examinations and or oral 
cancer risk assessments.  In addition, these individuals may not include the risk of oral 
cancer containing HPV in oral cancer education with their patients.  Their nonresponse 
could indicate there was undercoverage of this group in the sample (Moore, 2004).  
Individuals who did not complete the survey may not be aware of the prevalence 
of HPV in OPC.  These groups may have been underrepresented in the survey findings.  
Conversely, dental hygienists who have been educated about or feel strongly about oral 
HPV may have been over-represented.  This could not have been controlled for however, 
in a survey format.  The topic of the survey could be limiting in itself because some 
dental hygienists may not feel they can honestly answer questions about a sexually 
related topic due to their lack of knowledge and own discomfort discussing such topics.  
Regional and cultural differences may impact how comfortable dental hygienists are in 
responding to questions pertaining to this topic.   
Lastly, the survey was limited to dental hygienists so it does not imply patients 
are not receiving oral HPV education from dentists or other health care providers.  
Education from other health care providers was also not controlled for in this study.  
There is no account for education that adult children receive from sexual education or 
wellness programs in high schools, colleges, and universities.   
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Recommendations 
The results of this study clearly identify the need to increase oral HPV continuing 
education courses.  Professional organizations should consider developing training 
courses, including online courses, pertaining to the known facts about oral HPV cancers.  
Professional dental hygiene conferences should aim to include experts in the area of oral 
HPV to present at these large gatherings.   
Dental hygienists need guidelines for oral HPV screening and education from 
professional organizations to help determine if every patient should be informed about 
oral HPV and if not, which patients.  Risk assessments for oral HPV could help 
determine who is at risk.  Additional clinical research is still needed to determine what 
level of risk actually exists if a patient does contact oral HPV (Cleveland et al., 2011).  
Further research is needed to determine the effectiveness of patient knowing their oral 
HPV status.  If definite progress to OSCC is assumed, guidelines will be required for 
monitoring such at-risk patients. 
The development of patient education materials and content for dental hygienists 
to use in clinical practice is recommended.  As clinical studies continue to provide new 
oral HPV information, professional associations should consider providing members with 
accessible education pamphlets or posters to help educate patients on topics covering 
HPV OPC and related facts.  Professional organization’s communicating the known facts 
with dental hygienists will give these professionals confidence in the information they 
require to educate their patients.  This will prevent the media from misinforming patients.  
The patients look to dental professionals to provide the facts.  Professional associations 
should continue to develop new tools available for oral HPV education. 
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Dental hygiene educational programs should continue to monitor ADA and 
ADHA guideline releases related to oral HPV.  Oral pathology courses should continue to 
include oral HPV in their curriculum.  Course content including patient education, 
pathology screening techniques, and risk assessments should include applicable 
information about oral HPV for future dental hygiene graduates.  This is important if the 
prevalence trends hold true and the number of oral HPV cancers continue to rise.  
Given the outcomes of this study, specific recommendations are suggested to help 
the dental hygiene profession prepare for the rise in oral HPV (Table 19).    
Table 19 
Recommendations for Dental Hygiene Profession to Prepare for the Rise in Oral HPV 
 Methods 
Professional 
Organizations 
Oral HPV continuing education availability 
 Continuing education courses at state and national sessions  
 Online courses 
 Journal articles with CE 
Providing clear guidelines to determine patient’s risks 
 Oral HPV risk assessments 
 Guidelines for IO exams to include oropharynx 
 Patient education strategies to incorporate for different 
genders and age groups 
Provide known oral HPV facts via pamphlets and posters 
 
Encourage movement for Associate programs to become Bachelor’s 
degree programs 
Dental Hygiene Programs Include oral HPV in curriculum  
 Oral pathology 
 Patient education 
Simulations and role playing  
 
Encourage students with Associate degrees to further education with  
Bachelor’s degree completion programs 
Dental Hygienists Attend/complete oral HVP continuing education courses 
 
Inquire about oral HPV education office protocol with dentist 
Licensure Testing 
Agencies 
Inclusion of oral HPV knowledge and screening skills on licensing 
exams 
 
Evaluation of national program’s outcomes of including oral HPV in 
curriculums 
 
Evaluation of graduating students’ preparedness to educate and 
screen patients for oral HPV 
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Suggestions for Additional Research 
Further research to determine if patients are aware of oral HPV or if dentists or 
other health care providers are providing this information is needed to determine if there 
is a clear lack of oral HPV education.  A similar study to this one of all dental hygienists 
in the country could depict a clear representative data collection of current practice 
trends, feeling, and perception of the dental hygienists’ role in educating patients about 
risk of oral HPV.   
Further clinical research is needed to determine the exact known causes, risks, and 
likelihood of patients actually developing oral cancer from having oral HPV present in 
the oropharyngeal or oral cavity.  Ongoing research is necessary to include oral HPV as a 
preventive virus for the current vaccinations available.  Further studies should be 
completed to determine the effectiveness of testing for oral HPV presence in saliva in 
reducing the prevalence of oral HPV OSCC. 
Curriculum surveys of all dental hygiene programs in the US could help identify 
the depth of oral HPV education in curriculum.  These studies could also investigate if 
longer programs such as those granting Bachelor’s of Science degrees have an improved 
opportunity to include oral HPV information to existing patient education and pathology 
curriculum.  Upon surveying the schools, it would also be worthwhile to survey graduates 
to determine the preparedness they have going into the dental field on the topic of oral 
HPV education.  The National Board Dental Hygiene Examination could be evaluated to 
consider incorporating questions related to oral HPV associated risks on future exams.  
Lastly, regional clinical testing agencies could consider incorporating a head and neck 
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screening as part of the process of examining graduates of clinical preparedness for 
practice. 
Further research could investigate the outcomes of providing patient oral HPV 
education material, such as a pamphlet, at one appointment and following up with them 
subsequent appointments.  Looking at patient reception of this information, particularly 
of various age groups, would be helpful in creating patient education guidelines for dental 
hygienists addressing oral HPV.  Lastly, research could investigate dental hygienists and 
dentist feelings about oral HPV education and which dental team members should be 
addressing this topic with patients.   
Conclusions 
The research has defined that two types of oral cancer now exist; those caused by 
tobacco and alcohol use, and those with oral HPV present (D’Souza et al., 2007; Fakhry 
et al., 2008; Heck et al., 2010; Gillison et al., 2000; Klussman et al., 2009).  Those oral 
cancers caused by tobacco and alcohol use are declining across the US (Cleveland et al., 
2011; Herrero et al., 2003; Shiboski, Schmidt, & Jordan, 2005).  The oral cancers in the 
oropharynx with HPV present are rising across the nation (Cleveland et al., 2011; Herrero 
et al., 2003; Shiboski, Schmidt, & Jordan, 2005).  Specifically, they are rising in 
Caucasian men less than 60 years old (Chaturvedi et al., 2008; Ryerson et al., 2008). 
Patients coming into the dental office assume dental professionals not only 
examine for the presence of tooth decay and periodontal disease, but head and neck 
cancers as well. This study identified that dental hygienists recognize the increasing 
incidence of oral HPV as well as their responsibility to educate patients about these facts.  
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However, dental hygienists need clear guidelines, more continuing education, and patient 
educational materials to be fully competent. 
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Appendix A  
Email Introduction 
 
Hello, 
My name is Lacey Sandstrom.  I am a graduate student at Eastern Washington University 
in Cheney, Washington.  As part of my requirements for the Masters in Science in Dental 
Hygiene, I am conducting research for my thesis to investigate dental hygienists’ role in 
education of risks of oral cancers caused by human papillomaviruses.  The design of this 
research is quantitative in the form of a survey using the link below.  Upon completion of 
the study, the results will be published in my thesis document and available to 
participants for review. 
 
Participation in the study is voluntary and anonymous.  You may skip any question you 
do not feel comfortable answering.  Consent for the survey will be assumed by 
completion.   
 
There will be a random drawing for participants in each selected state for a $25 iTunes 
gift card.  If you would like to participate in the drawing, please send a reply to this email 
address (lsandstrom@eagles.ewu.edu) after you have completed the survey.  In the 
subject box, please type the state in which you practice dental hygiene.  The reply will 
automatically enter you into the drawing for your state.  If you are selected, I will notify 
you through email.  I will send you the card or email you the code based on your 
preference. 
 
If you have any questions or concerns about this survey please contact myself at 406-698-
2418, lsandstrom@eagles.ewu.edu or my thesis advisor Rebecca Stolberg at 509-828-
1298, rstolberg@ewu.edu.  If you have any concerns about your rights as a participant in 
this research or any complaints you wish to make, you may contact Ruth Galm, Human 
Protections Administrator at Eastern Washington University (509-359-7971/6567), 
rgalm@ewu.edu. 
 
Thank you very much for your consideration and time in completing this survey for my 
research.  
 
Please click on this link to begin the survey: 
https://www.surveymonkey.com/s/RDHroleinoralHPVeducation 
 
Lacey Sandstrom, RDH, BSDH 
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Appendix B  
Survey 
Survey Questions: Thank you for taking the time to complete this short survey regarding 
your awareness, knowledge, and perception about oral HPV education.  For each of the 
following statements, please choose the most accurate answer.  Please select only one 
answer unless otherwise indicated.  
1. In what region of the United States do you practice dental hygiene? 
o Connecticut 
o Wisconsin 
o Mississippi 
o Oklahoma 
o Washington 
2. Which is the population density of the city or town in which you practice? 
o Urban (More than 50,000 people per city) 
o Rural  (Less than 50,000 people per city) 
3. What is your age? 
o 30 and younger 
o 31-40 
o 41-50 
o 51 and older 
4. What is your gender? 
o Female 
o Male 
5. What is the highest educational degree you have earned in dental hygiene? 
o Certificate 
o Associate 
o Bachelor’s of Science 
o Master’s Degree 
6. What is your practice setting? (select all that apply) 
o Private Practice 
o Public Health 
o Specialty Practice    Which? ____________________ 
o Educational Clinic 
o Research Facility 
o Hospital 
o Cancer Care Center 
7. How long have you practiced dental hygiene? 
o 0-3 years 
o 4-6 years 
o 7-10 years 
o 10-15 years 
o 15+ years 
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8. How often do you perform an intraoral screening for your patients? 
o Every patient  
o Rarely 
o Some of the time (select your most likely reason) 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus 
(HPV) 
o I do not perform intraoral screenings 
9. If you selected ‘some of the time’, select all that apply 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus (HPV) 
10. How often do you complete an oral cancer risk assessment for your patients?  
o On every patient  
o Rarely 
o Some of the time (select your most likely reason) 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus 
(HPV) 
o Our patients do not complete a risk assessment for oral cancer (go to 
question 13) 
11. If you selected ‘some of the time’, select all that apply 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus (HPV) 
 
 
 
 127 
DENTAL HYGIENISTS AND HUMAN PAPILLOMAVIRUSES     
 
12. Which types of questions are included in your risk assessment for oral cancer? 
(select all that apply) 
o Tobacco history 
o Tobacco use frequency 
o Alcohol history 
o Alcohol use frequency 
o Marijuana history 
o Marijuana use frequency 
o Sexual history 
o HPV history 
13. How often do you discuss the risk of oral cancers developing with HPV 
present? 
o With every patient 
o Some of the time (select your most likely reason) 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus 
(HPV) 
o I do not discuss oral HPV cancer risks with my patients (go to 
question 15) 
14. If you selected ‘some of the time’, select all that apply 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus (HPV) 
15. How often do you discuss with your patients how HPV can be transmitted to 
the oropharynx and oral cavity? 
o On every patient 
o Some of the time (select your most likely reason) 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus 
(HPV) 
o I do not discuss the mode of transmission with oral HPV (go to 
question 17) 
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16. If you selected ‘some of the time’, select all that apply 
o If I have time at the end of the appointment 
o If I see suspicious tissue 
o If the patient has an area of concern 
o If the patient has a history or uses tobacco products 
o If the patient has a history of or abuses alcohol 
o If the patient has a history or uses marijuana 
o If the patient has a history of or has human papillomavirus (HPV) 
17. How knowledgeable are you in discussing HPV and oral cancer risk with your 
patients? 
o Very knowledgeable  
o Somewhat knowledgeable 
o Knowledgeable  
o Unknowledgeable  
o Very Unknowledgeable  
18. What do you think the rate of occurrence is with the incidence of oral HPV in 
oropharyngeal cancers?   
o It is declining 
o It is rising 
o There has been no change 
o There is no prevalence  
19. What do you think is the mode of transmission with oral HPV? 
o Sexual contact 
o Oral sexual contact 
o Kissing 
o It is unknown 
o History of genital HPV 
20. Who do you feel is at the highest risk for developing oral cancers caused by 
HPV? (select all that apply)   
o Men 
o Women 
o Age 20-55 
o Age 55+ 
o Heterosexuals 
o Homosexuals 
o Caucasian  
o African American 
o Mexican and Native Americans 
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21. Where would you most likely find oral cancer caused by HPV? (select all that 
apply) 
o The hard palate 
o The dorsal surface of the tongue 
o The lateral border of the tongue 
o The vestibules 
o The lingual tonsils 
o The floor of the mouth 
o The palatal tonsils 
22. How comfortable do you feel discussing the risk of oral cancer caused by 
HPV with your patients?   
o Very comfortable 
o Fairly comfortable 
o Comfortable 
o Uncomfortable 
o Very uncomfortable  
23. How likely would you recommend a patient consider HPV vaccinations? 
o Very likely 
o Somewhat likely 
o Likely 
o Unlikely 
o Very unlikely  
24. If you are uncomfortable discussing HPV with your patients, what barriers 
prevent you from doing so?   
25. Do you think your patients will be receptive to oral HPV education?  Why or 
why not? 
26. Do you feel oral HPV education should be provided by dental hygienists?  If 
not, what health care professional should provide education about oral HPV? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 130 
DENTAL HYGIENISTS AND HUMAN PAPILLOMAVIRUSES     
 
 
 
 
Appendix C 
 
Table C1 
Dental Hygienists’ Knowledge of Oral HPV Incidence Changes 
 
 
Response Rates  
N % p-value 
Mode of Transmission  
Declining 
Rising 
No Change 
No Prevalence 
Responses by Independent Variable 
State 
Population Density 
Age 
Gender 
Educational Level 
Year in Practice 
 
1 
400 
14 
1 
 
 
0.24 
96.15 
3.37 
0.24 
 
 
 
 
 
 
 
 
 
 
 
 
0.2128** 
0.6594** 
0.1391** 
0.6176** 
 0.3249**
+ 
0.0619** 
Mode of Transmission  
Oral sexual contact  
Sexual contact  
Kissing  
Unknown cause  
History of genital HPV 
Responses by Independent Variable 
State 
Population Density 
Age 
Gender 
Educational Level 
Year in Practice 
 
39 
323 
8 
13 
30 
 
78.21 
9.44 
1.94 
3.15 
7.26 
 
 
 
 
 
 
 
0.2026** 
0.7176** 
0.5537** 
0.0070** 
0.2748** 
0.5146** 
Note: p-values based from x
2 
contingency analysis comparing incidence rising 
versus no change with Contingency Analysis.  Confidence Interval, α=0.05. 
*p<0.05.  **Frequencies included some with less than 5.  Caution should be 
used when considering these statistics. 
 +
Excludes certification results. 
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Table C2 
Dental Hygienists’ Feelings of Likeliness to Discuss HPV Vaccine Availability by Age 
 Comfortable Uncomfortable 
 Very Somewhat Normal Somewhat Very 
 fo fe fo fe fo fe fo fe fo fe 
Years in 
Practice 
0-3 
4-6 
7-10 
10-15 
15< 
 
 
15 
10 
9 
13 
48 
 
 
17 
11 
10 
14 
43 
 
 
12 
6 
7 
13 
45 
 
 
15 
10 
8 
12 
38 
 
 
20 
19 
5 
9 
35 
 
 
14 
10 
8 
12 
36 
 
 
116 
20 
15 
17 
43 
 
 
20 
13 
11 
17 
51 
 
 
11 
4 
6 
11 
20 
 
 
9 
6 
5 
8 
24 
P-value 0.8976 0.4484 0.3326 0.1357 0.5408 
Note: p-values based from x
2 
independence analysis comparing incidence rising versus no 
change with Goodness-of-Fit.  Confidence Interval, α=0.05. *p<0.05.   
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 Granger, Amie 
 Webb, Cassie 
 
Dental Hygiene Class of 2014 
 Garcia, Elizabeth 
 Graves, Taira (1 semester)  
 Roosa, Chenel  
 Wagner, Angela  
 
Dental Hygiene Class of 2015 
 Bartley, Jamie (1 semester) 
 Mannering, Kristen  
 Morris, Kamiree  
 Strain, Mijkan  
 
 
 
 
 
 
LEADERSHIP COURSES: 
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The Global Leadership Summit 2013; Teleconference in Sheridan, Wyoming. 
August 2013 
It Worked For Me.  General Colin Powell 
How to Lose Your Best People.  Patrick Lencioni 
The Multiplier Effect.  Liz Wiseman 
Right Title…Wrong Kingdom.  Chris Brown. 
Love Takes Action.  Bob Goff 
Unscripted Leadership.  Mark Burnett 
Mastering the Skill of Influence.  Joseph Grenny 
The Innovation Challenge: Getting it Right.  Vijay Govindarajan 
Daring Greatly.  Dr. Brene Brown 
Viral Leadership: Multiplying Your Impact Exponentially.  Oscar Muriu 
Reversing the Death Spiral of  Leader.  Dr. Henry Cloud 
 
CONTINUING EDUCATION COURSES 
Wyoming Dental Hygienists’ Association Annual Session; Casper, Wyoming.  
September 2013 
Oral Health and Disease in HIV/AIDS.  David Reznik, DDS.  2.5 CE credits 
Emergency Medicine – Back to Basics.  Stanley F. Malamed, DDS.  3 CE credits 
What’s New in Local Anesthesia.  Stanley F. Malamed, DDS.  3 CE credit 
 
Wyoming Dental Hygienists’ Association Annual Session; Casper, Wyoming.  
September 2012 
Signs of Skin Cancer.  Nancy Brown, NP.  2 CE credits 
Discoveries Beyond the Naked Eye.  Pat Pine, RDH.  4 CE credits 
Dental Health for the Cancer Patient.  JoAnn Ramsey, PA-C.  1 CE credit. 
 
Review of Head and Neck Anatomy.  Dr. Vera A. Brown, DMD, ART Provider.  Live 
Internet Webcast Course.  August 28, 2012.  3 CE 
 
Rocky Mountain Dental Convention; Denver, Colorado.  January 2012 
Hygiene Fast Track: Pre-medicate. John McDowell. 1 CE credit 
Hygiene Fast Track: Dental Hygiene Ethics. Terri Tilliss. 1 CE credit 
Hygiene Fast Track: Secrets to Profound Local Anesthesia and How to Avoid 
Complications. Jeff Stearns. 1 CE credit 
The Impact of Street and Prescription Drugs on You and Your Dental Practice. Harold 
Crossley. 2.5 CE credits 
Hot Topics in Periodontics for the Dental Hygienist. Rebecca Wilder. 3 CE credits 
American Dental Hygienists’ Association Annual Session; Nashville, TN. June 2011 
How To Implement a Community-Based Oral Health Program. A. Druann Andrecht, 
RDH; P. Yamagata, RDH, Med; N. Starr, RDH, MPH. 3 CE credits 
Medical Emergencies: Essentials for the Dental Professional.  Ellen Grimes, RDH, MA, 
MPA, Ed.D. 2 CE credits 
A Linda DeVore Lecture: Evidence-Based Teaching: Studies Directly Related to Student 
Learning. Adam Persky, PhD. 3 CE credits 
Research Poster Sessions & Student Table Clinics/Poster Sessions. 2 CE credits 
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Why It’s Time to Incorporate Salivary Diagnostics into Your Practice.  Dr. Doug 
Thompson; Gwen Smukowski, RDH, MBA.  2 CE credits 
Student Advisor Workshop. 
 
Designing and Developing an Online Course; Sheridan College; Sheridan, Wyoming.  
Fall 2010.  Stoney Gaddy.  2 semester credits. 
 
Rocky Mountain Dental Convention; Denver, Colorado.  January 2011 
Laser Perio For Hygienists. Dr. Robert Convissar. 3 CE credits 
Explaining Bleeding Bugs and Bad Breath to Patients, Session 2.  Ms. Trisha O’Hehir. 1 
CE credit. 
 
Video Atlas of Human Anatomy by Robert D. Acland, FRCS.  DVD 4 and Tape 5. 
2010, 2011, 2012 
 
Rocky Mountain Dental Convention; Denver, Colorado.  January 2010 
Strategies for Oral Health and Patient Compliance. Janette Delinger, RDH, BSDH. 2.5 
CE credits 
Bacteria Busters: The Hygiene CSI of the Mouth.  Stephanie Pietrantonio. 3 CE credits 
Advanced Periodontal Instrumentation Update 2010. Anna Matsuishi Pattison. 3 CE 
credits 
Cracking the Code: CDT 2009-2010. Dr. Mary Smith. 2.5 CE credits 
 
Wyoming Dental Hygienists’ Association Annual Session; Casper, Wyoming.  
September 2010 
Best Practices for Improving Oral Healthcare.  Frieda Pickette, RDH, MS.  3 CE credits 
 
Eastern Washington University Dental Hygiene Faculty In-Service; Spokane, 
Washington.  September 2009.  Clinical Calibration, OSHA Update, New Clinical 
Technology, Professionalism and Simulation. 8 CE Credits 
 
Teaching Methodology; online.  December 2009. 
Teaching Styles.  Patricia Dray, RDH. 
 
Competency Based and Learner-Centered Teaching; Sheridan, Wyoming.  August 
2009. 
 
On-site Eagle Soft Training; Sheridan, Wyoming.  August 2009 
 
Rocky Mountain Dental Convention; Denver, Colorado.  January 2009 
Incorporating Quality Perio into Comprehensive Restorative Dentistry.  Dr. Sam Low. 3 
CE credits 
Infection Control Update.  Dr. John Molinari.  3 CE credits 
Caries Risk Assessment: Utilizing the Powerful Tool to Treat and Prevent Caries.  Dr. 
Fotinos Panagakos. 2 CE credits 
Non-Carious Cervical Lesions. Dr. Eric Van Zytveld.  1 CE credit 
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Medical Emergencies in the Office and in Life.  Dr. J. Mel Hawkins.  3 CE credits 
   
On-site Dentrix Training; Miles City, Montana.  December 2008 
 
On-site Dexis Training; Miles City, Montana. December 2008 
 
Rocky Mountain Dental Convention; Denver, Colorado.  January 2008 
The Impact of Herbal Medicine on Clinical Dentistry. Karen Baker, M.S., R.Ph. 2.5 CE 
credits 
Clinical Oral Pathology for Your Everyday Practice: Skin and Soft Tissue Lesions. Dr. 
Kitrina Cordell.  2.5 CE credits 
An Update in Periodontics: What Every Hygienist Should Know! Ms. Jill Rethman. 2.5 
CR credits 
 
Fortune Management Course; LaFayette, Colorado.  September 2007 
Getting Your Patients to Say Yes Predictably.  Rene Schubert.  6 CE credits 
 
Rocky Mountain Dental Hygiene Study Club Seminar; Fort Collins, Colorado.  April 
2007. 
Periodontal Potpourri: Oral Pathology Review, Mucogingival Defects, Periodontal 
Surgery Review, and Classification Epidemiology, and Diagnosis of Periodontal Disease.  
Dr. Leslie Paris.  5 CE credits 
 
Rocky Mountain Dental Convention; Denver, Colorado.   January 2007 
Think outside the mouth: Treatment for non-Surgical Periodontal Treatment. Karen 
Davis, RDH. 2.5 CE credits 
Systemic Perio: Where is the Link? Dr. Joan Otomo-Corgel.  3 CE credits 
Beyond the Boundaries: Comprehensive & Profitable Hygiene Departments.  Karen 
Davis, RDH. 2.5 CE credits 
 
Montana Dental Hygienists’ Association Annual Session; Helena, Montana.  April 
2006. 
A Day of Discovery, Update, and Advanced Instrumentation.  Jodi Deming, R.D.H.  6 
CE credits 
 
Nobel Biocare Course; Billings, Montana.  February 2006 
Implant Restorative Overview.  Dr. Christopher B. Marchack.  7 CE credits 
 
Montana 9
th
 District Dental Society Mid-Winter Meeting; Billings, Montana.  January 
2006. 
Current Trends in Dental & Medical Quackery.  Robert S. Baratz, MD, DDS, PhD and 
Stephen Barrett, MD.  7 CE credits 
An Overview of Forensic Odontology.  Dr. John D. McDowell.  7 CE credits 
 
 
